Renovare Environmental (RENO) 10-Q 19 Nov 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2020	Nov. 16, 2020
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity Registrant Name	BIOHITECH GLOBAL, INC.
Entity Central Index Key	0001590383
Entity Common Stock, Shares Outstanding		23,354,130
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Shell Company	false
Trading Symbol	BHTG
Title of 12(b) Security	Common Stock, $0.0001 par value per share
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false
Entity Small Business	true

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenue
Total revenue	$ 742,877	$ 1,426,775	$ 3,376,150	$ 3,212,689
Operating expenses
Cost of revenue		24,537	41,514	73,611
Selling, general and administrative	1,924,293	1,449,545	5,740,158	5,450,282
Impairment expense	917,420		917,420
Depreciation and amortization	562,143	611,368	1,747,109	1,350,780
Total operating expenses	4,660,333	3,042,020	12,052,802	8,674,904
Loss from operations	(3,917,456)	(1,615,245)	(8,676,652)	(5,462,215)
Other (income) expenses
Gain on sale of affiliate investment		(562,617)		(562,617)
Interest (income)	(108)	(46,180)	(17,730)	(46,180)
Interest expense	1,023,165	979,202	3,060,775	2,281,071
Expense incurred in warrant valuation and conversions		49,160		49,160
Total other (income) expenses	1,023,057	419,565	3,043,045	1,721,434
Net loss	(4,940,513)	(2,034,810)	(11,719,697)	(7,183,649)
Net loss attributable to non-controlling interests	(1,647,782)	(728,337)	(3,190,788)	(1,859,069)
Net loss attributable to Parent	(3,292,731)	(1,306,473)	(8,528,909)	(5,324,580)
Other comprehensive income
Foreign currency translation adjustment	71,067	(32,676)	40,931	(37,873)
Comprehensive loss	(3,221,664)	(1,339,149)	(8,487,978)	(5,362,453)
Net loss attributable to Parent	(3,292,731)	(1,306,473)	(8,528,909)	(5,324,580)
Preferred stock dividends	(205,115)	(255,847)	(587,428)	(548,075)
Deemed dividend on down round feature	(21,738)	(405,324)	(21,738)	(405,324)
Net loss - common shareholders	$ (3,519,584)	$ (1,967,644)	$ (9,138,075)	$ (6,277,979)
Net loss per common share - basic and diluted	$ (0.16)	$ (0.13)	$ (0.49)	$ (0.41)
Weighted average number of common shares outstanding - basic and diluted	22,044,540	15,649,174	18,787,566	15,134,301
HEBioT (related entity)
Revenue
Revenue	$ 625	$ 609,905	$ 1,383,656	$ 886,947
Operating expenses
Cost of revenue	945,810	786,680	2,778,514	1,309,176
Rental, service and maintenance
Revenue
Revenue	423,996	489,555	1,251,122	1,426,193
Operating expenses
Cost of revenue	139,665	176,651	552,195	508,164
Equipment sales
Revenue
Revenue	293,876	62,565	616,992	137,799
Operating expenses
Cost of revenue	171,002	17,776	317,406	56,502
Management advisory and other fees (related party)
Revenue
Revenue	$ 24,380	$ 264,750	$ 124,380	$ 761,750

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Current Assets
Cash	$ 4,950,112	$ 1,847,526
Restricted cash	1,287,138	1,133,581
Accounts receivable, net of allowance for doubtful accounts of $194,066 and $170,038 as of September 30, 2020 and December 31, 2019, respectively (related entity $2,227,224 and $1,370,867 as of September 30, 2020 and December 31, 2019, respectively)	3,311,519	2,155,921
Inventory	627,261	467,784
Prepaid expenses and other current assets	240,939	126,357
Total Current Assets	10,416,969	5,731,169
Restricted cash	2,646,448	2,555,845
Equipment on operating leases, net	1,417,260	1,724,998
HEBioT facility, equipment, fixtures and vehicles, net	36,338,727	37,421,333
Operating lease right of use assets	1,285,292	945,047
License and capitalized MBT facility development costs	8,018,853	8,049,929
Goodwill	58,000	58,000
Other assets	33,749	53,726
Total Assets	60,215,298	56,540,047
Current Liabilities:
Line of credit, net of financing costs of $2,050 and $20,152 as of September 30, 2020 and December 31, 2019, respectively	1,497,950	1,479,848
Advances from related parties	935,000	210,000
Accounts payable (related entity $2,021,940 and $2,531,034 as of September 30, 2020 and December 31, 2019, respectively)	6,363,168	4,688,339
Accrued interest payable	627,112	1,148,570
Accrued expenses and liabilities	2,075,576	1,926,965
Deferred revenue	95,331	89,736
Customer deposits	753,046	44,792
Note payable	0	100,000
Senior Secured Note , net of financing costs of $75,767 and unamortized discounts of $515,719 as of September 30, 2020	4,408,514
Current portion of WV EDA Senior Secured Bonds payable	2,860,000	1,390,000
Current portion of long term debt and Payroll Protection Program Loan	261,787	4,605
Total Current Liabilities	19,877,484	11,082,855
Junior note due to related party, net of unamortized discounts of $84,110 and $95,043 as of June 30, 2020 and December 31, 2019, respectively	965,881	949,434
Accrued interest (related party)	1,729,605	1,510,193
WV EDA Senior Secured Bonds payable, net of current portion, and financing costs of $1,691,516 and $1,792,574 as of September 30, 2020 and December 31, 2019, respectively	28,448,484	29,817,426
Payroll Protection Program Loan, net of current portion	163,839
Senior Secured Note, net of current portion, net of financing costs of $113,268, and unamortized discounts of $726,242, as of December 31, 2019		4,160,490
Note payable	100,000
Non-current lease liabilities	1,231,144	915,170
Long-term debt, net of current portion	4,936	8,201
Total Liabilities	52,521,373	48,443,769
Series A redeemable convertible preferred stock, 333,401 shares designated and issued, and 125,312 and 145,312 outstanding as of September 30, 2020 and December 31, 2019, respectively	626,553	726,553
Commitments and Contingencies
Stockholders' Equity
Preferred Stock, Value, Issued
Common stock, $0.0001 par value, 50,000,000 shares authorized, 23,354,130 and 17,300,899 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively	2,334	1,730
Additional paid in capital	59,775,963	49,597,059
Accumulated deficit	(61,403,226)	(52,785,242)
Accumulated other comprehensive (loss)	(84,069)	(43,138)
Stockholders' equity attributable to Parent	4,912,578	2,024,143
Stockholders' equity attributable to non-controlling interests	2,154,794	5,345,582
Total Stockholders' Equity	7,067,372	7,369,725
Total Liabilities and Stockholders' Equity	60,215,298	56,540,047
Series B Convertible Preferred Stock [Member]
Stockholders' Equity
Preferred Stock, Value, Issued	0	0
Series C Convertible Preferred Stock [Member]
Stockholders' Equity
Preferred Stock, Value, Issued	3,050,142	3,050,142
Series D Convertible Preferred Stock
Stockholders' Equity
Preferred Stock, Value, Issued	1,365,696	1,505,262
Series E Convertible Preferred Stock [Member]
Stockholders' Equity
Preferred Stock, Value, Issued	698,330	698,330
Series F Convertible Preferred Stock [Member]
Stockholders' Equity
Preferred Stock, Value, Issued	$ 1,507,408	$ 0

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Preferred Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred stock, Designated shares	3,209,210	3,179,120
Preferred Stock, Shares Issued	1,936,214	1,922,603
Preferred Stock, Shares Outstanding	848,292	856,181
Common Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	23,354,130	17,300,899
Common stock, shares outstanding	23,354,130	17,300,899
Deferred finance cost current	$ 2,050	$ 20,152
Accounts Receivable, Related Parties, Current	2,227,224	1,370,867
Accounts Payable, Related Parties, Current	2,021,940	2,531,034
Allowance for Doubtful Accounts Receivable, Current	194,066	170,038
Junior Notes [Member]
Due to Related Parties, Noncurrent	78,596	95,043
Senior Notes [Member]
Debt Issuance Costs, Noncurrent, Net	113,268
Debt Instrument, Unamortized Discount, Noncurrent		726,242
Deferred finance cost current	75,767
Debt Instrument, Unamortized Discount, Current		515,719
WV EDA SENIOR NOTES [Member]
Debt Issuance Costs, Noncurrent, Net	$ 1,691,516	$ 1,792,574
Series A Redeemable Convertible Preferred Stock
Preferred stock, Designated shares	333,401	333,401
Preferred Stock, Shares Issued	333,401	333,401
Preferred Stock, Shares Outstanding	125,312	145,312
Series B Convertible Preferred Stock [Member]
Preferred stock, Designated shares	1,111,200	1,111,200
Preferred Stock, Shares Issued	428,333	428,333
Preferred Stock, Shares Outstanding	0	0
Series C Convertible Preferred Stock [Member]
Preferred stock, Designated shares	1,000,000	1,000,000
Preferred Stock, Shares Issued	427,500	427,500
Preferred Stock, Shares Outstanding	427,500	427,500
Series D Convertible Preferred Stock
Preferred stock, Designated shares	20,000	20,000
Preferred Stock, Shares Issued	18,850	18,850
Preferred Stock, Shares Outstanding	17,350	18,850
Series E Convertible Preferred Stock [Member]
Preferred stock, Designated shares	714,519	714,519
Preferred Stock, Shares Issued	714,519	714,519
Preferred Stock, Shares Outstanding	264,519	264,519
Series F Convertible Preferred Stock [Member]
Preferred stock, Designated shares	30,090
Preferred Stock, Shares Issued	13,611
Preferred Stock, Shares Outstanding	13,611	0

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net loss	$ (11,719,697)	$ (7,183,649)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation and amortization	1,747,109	1,350,780
Impairment expense	917,420
Amortization of operating lease right of use assets	72,402
Provision for bad debts	126,119	45,000
Share based employee compensation	1,537,915	741,188
Interest resulting from amortization of financing costs and discounts	419,715	333,782
Share based vendor compensation	297,835
Gain on sale of affiliate investment		(562,617)
Loss resulting from write-off of proposed MBT site		346,654
Warrants modification		49,160
Changes in operating assets and liabilities	(909,507)	(1,137,810)
Net cash used in operating activities	(7,510,689)	(6,017,512)
Cash flow from investing activities:
Purchases of construction in-progress, equipment, fixtures and vehicles	(207,173)	(4,619,883)
Proceeds from sale of investment in affiliate		2,250,000
Refund of deposit	5,000
MBT facility development costs incurred	(62,949)	(59,013)
MBT facility development costs refunded		66,000
Net cash used in investing activities	(265,122)	(2,362,896)
Cash flows from financing activities:
Proceeds from common stock issuance, net of offering costs	8,437,480	3,035,557
Proceeds from Payroll Protection Program Loan	421,300
Affiliate investment in subsidiary		1,400,000
Deferred financing costs incurred		(62,151)
Repayments of long-term debt	(3,544)	(6,846)
Related party advances, net	725,000	210,000
Net cash provided by financing activities	11,140,686	6,349,060
Effect of exchange rate on cash (restricted and unrestricted)	(18,129)	12,721
Net change in cash (restricted and unrestricted)	3,346,746	(2,018,627)
Cash - beginning of period (restricted and unrestricted)	5,536,952	9,126,380
Cash - end of period (restricted and unrestricted)	8,883,698	7,107,753
Series F Convertible Preferred Stock [Member]
Cash flows from financing activities:
Proceeds from the sale of convertible preferred stock units	$ 1,560,450
Series D Convertible Preferred Stock
Cash flows from financing activities:
Proceeds from the sale of convertible preferred stock units		$ 1,772,500

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Preferred Stock [Member]Series D Preferred Stock [Member]	Preferred Stock [Member]Series F Preferred Stock [Member]	Preferred Stock [Member]Series E Preferred Stock [Member]	Preferred Stock [Member]	Common Stock [Member]Series D Preferred Stock [Member]	Common Stock [Member]Series E Preferred Stock [Member]	Common Stock [Member]	Additional Paid in Capital [Member]Series D Preferred Stock [Member]	Additional Paid in Capital [Member]Series F Preferred Stock [Member]	Additional Paid in Capital [Member]Series E Preferred Stock [Member]	Additional Paid in Capital [Member]	Accumulated Comprehensive Other Loss [Member]	Accumulated Deficit [Member]Series D Preferred Stock [Member]	Accumulated Deficit [Member]	Non-Controlling Equity Interest [Member]	Series D Preferred Stock [Member]	Series F Preferred Stock [Member]	Total
Balance at Dec. 31, 2018				$ 4,540,472			$ 1,480				$ 43,452,963	$ 5,021		$ (44,594,385)				$ 3,405,551
Balance (in shares) at Dec. 31, 2018				992,019			14,802,956
Issuance of registered common shares, net of offering costs	$ 1,505,262		$ (792,000)			$ 30	$ 188	$ 267,238		$ 791,970	3,035,369					$ 1,772,500		3,035,557
Issuance of registered common shares, net of offering costs (in shares)	18,850		(300,000)			300,000	1,877,666
Share-based employee and director compensation																		741,188
Share-based employee and director compensation											741,188
Preferred stock dividends							$ 3				49,997			(140,631)				(90,631)
Preferred stock dividends (in shares)							27,778
Issuance of restricted stock							$ 11				205,489							205,500
Issuance of restricted stock (shares)							105,000
Conversion of Series A preferred stock, and payment of accrued dividends in common stock							$ 5				89,995							90,000
Conversion of Series A preferred stock, and payment of accrued dividends in common stock (in shares)							50,000
Foreign currency translation adjustment												37,873						37,873
Warrant modification											49,160							49,160
Deemed dividend on down round feature											405,324			(405,324)
Net loss														(5,324,580)				(5,324,580)
Balance at Dec. 31, 2018														(76,890)	$ 6,679,585			6,602,695
Investment by non-controlling interest															1,400,000			1,400,000
Net Loss														(1,859,069)				(1,859,069)
Balance at Sep. 30, 2019														(1,935,959)	8,079,585			6,143,626
Balance at Sep. 30, 2019				$ 5,253,734			$ 1,717				49,088,693	42,894		(50,464,920)				3,922,118
Balance (in shares) at Sep. 30, 2019				710,869			17,163,400
Balance at Jun. 30, 2019				$ 5,268,734			$ 1,521				45,249,263	10,218		(48,649,236)				1,880,500
Balance (in shares) at Jun. 30, 2019				710,869			15,207,956
Issuance of registered common shares, net of offering costs	$ (15,000)						$ 188				3,035,369					$ (15,000)		3,035,557
Issuance of registered common shares, net of offering costs (in shares)							1,877,666
Share-based employee and director compensation																		209,585
Share-based employee and director compensation											209,585
Preferred stock dividends							$ 3				49,997			(103,887)				(53,887)
Preferred stock dividends (in shares)							(27,778)
Conversion of Series A preferred stock, and payment of accrued dividends in common stock							$ 5				89,995							90,000
Conversion of Series A preferred stock, and payment of accrued dividends in common stock (in shares)							50,000
Foreign currency translation adjustment												32,676						32,676
Warrant modification											49,160							49,160
Deemed dividend on down round feature											405,324			(405,324)
Net loss														(1,306,473)				(1,306,473)
Balance at Jun. 30, 2019														(1,207,622)	8,079,585			6,871,963
Net Loss														(728,337)				(728,337)
Balance at Sep. 30, 2019														(1,935,959)	8,079,585			6,143,626
Balance at Sep. 30, 2019				$ 5,253,734			$ 1,717				49,088,693	42,894		(50,464,920)				3,922,118
Balance (in shares) at Sep. 30, 2019				710,869			17,163,400
Balance at Dec. 31, 2019				$ 5,253,734			$ 1,730				49,597,059	(43,138)		(52,785,242)				2,024,143
Balance (in shares) at Dec. 31, 2019				710,869			17,300,899
Issuance of registered common shares, net of offering costs	$ (139,566)	$ 1,507,408			$ 9		$ 523	153,945	$ 53,042		8,436,957		$ (14,388)				$ 1,560,450	8,437,480
Issuance of registered common shares, net of offering costs (in shares)	(1,500)	13,611			91,328		5,232,500
Share-based employee and director compensation							$ 13											1,065,269
Share-based employee and director compensation (in shares)							132,400
Share-based employee and director compensation											1,065,256
Preferred stock dividends paid in common stock							$ 2				42,838							42,840
Preference stock dividend issued for common stock (In shares)							23,801
Preferred stock dividends														(52,949)				(52,949)
Conversion of Series A preferred stock, and payment of accrued dividends in common stock							$ 6				107,344							107,350
Conversion of Series A preferred stock, and payment of accrued dividends in common stock (in shares)							59,639
Payments in common stock and warrants to vendors and creditors							$ 14				297,821							$ 297,835
Payments in common stock and warrants to vendors and creditors (in shares)							141,259											141,259
Foreign currency translation adjustment												(40,931)						$ (40,931)
Deemed dividend on down round feature											21,738			(21,738)
Net loss														(8,528,909)				(8,528,909)
Balance at Dec. 31, 2019														(2,734,003)	8,079,585			5,345,582
Warrants exercised							$ 37				(37)
Warrants exercised (in shares)							372,304
Net Loss														(3,190,788)				(3,190,788)
Balance at Sep. 30, 2020														(5,924,791)	8,079,585			2,154,794
Balance at Sep. 30, 2020				$ 6,621,576			$ 2,334				59,775,963	(84,069)		(61,403,226)				4,912,578
Balance (in shares) at Sep. 30, 2020				722,980			23,354,130
Balance at Jun. 30, 2020				$ 6,761,142			$ 1,780				50,267,673	(13,002)		(58,056,529)				(1,038,936)
Balance (in shares) at Jun. 30, 2020				724,480			17,809,592
Issuance of registered common shares, net of offering costs	$ (139,566)				$ 9		$ 523				8,436,957		$ (14,388)					8,437,480
Issuance of registered common shares, net of offering costs (in shares)	(1,500)				91,328		5,232,500
Share-based employee and director compensation							$ 1											472,647
Share-based employee and director compensation (in shares)							9,900
Share-based employee and director compensation								$ 153,945			472,646
Preferred stock dividends paid in common stock							$ 1				17,839							17,840
Preference stock dividend issued for common stock (In shares)							9,912
Preferred stock dividends														(17,840)				(17,840)
Conversion of Series A preferred stock, and payment of accrued dividends in common stock							$ 6				107,344							107,350
Conversion of Series A preferred stock, and payment of accrued dividends in common stock (in shares)							59,639
Payments in common stock and warrants to vendors and creditors							$ 14				297,821							297,835
Payments in common stock and warrants to vendors and creditors (in shares)							141,259
Foreign currency translation adjustment												(71,067)						(71,067)
Deemed dividend on down round feature											21,738			(21,738)
Net loss														(3,292,731)				(3,292,731)
Balance at Jun. 30, 2020														(4,277,009)	8,079,585			3,802,576
Net Loss														(1,647,782)				(1,647,782)
Balance at Sep. 30, 2020														(5,924,791)	$ 8,079,585			2,154,794
Balance at Sep. 30, 2020				$ 6,621,576			$ 2,334				$ 59,775,963	$ (84,069)		$ (61,403,226)				$ 4,912,578
Balance (in shares) at Sep. 30, 2020				722,980			23,354,130

Basis of Presentation and Going

Basis of Presentation and Going Concern	9 Months Ended
	Sep. 30, 2020
Basis of Presentation and Going Concern
Basis of Presentation and Going Concern	Note 1. Basis of Presentation and Going Concern Nature of Operations - BioHiTech Global, Inc. (the “Company” or “BioHiTech”) through its wholly-owned and controlled subsidiaries, provides cost-effective and sustainable environmental management solutions. Our cost-effective technology solutions include the patented processing of municipal solid waste into a valuable renewable fuel, biological disposal of food waste on-site, and proprietary real-time data analytics tools to reduce food waste generation. Our solutions enable businesses and municipalities of all sizes to lower disposal costs while having a positive impact on the environment. When used individually or in combination, our solutions lower the carbon footprint associated with waste transportation and can reduce or virtually eliminate landfill usage. In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (COVID-19) as a pandemic which continues to spread throughout the United States and globally and more recently in the United States there has been an increase in cases reported. During October and November 2020 a resurgence in cases and hospitalizations has occurred. The Company is monitoring the near term and longer term impacts of COVID-19 and the related business and travel restrictions and changes to behavior intended to reduce its spread, and its impact on operations, financial position, cash flows, inventory, supply chains, purchasing trends, customer payments, and the industry in general, in addition to the impact on its employees. Due to the development and fluidity of this situation, the magnitude and duration of the pandemic and its impact on the Company's operations, liquidity and financial performance will depend on certain developments, including duration, spread and reemergence of the outbreak, its impact on our customers, supply chain partners and employees, and the range of governmental and community reactions to the pandemic, which are uncertain and cannot be fully predicted at this time. As a result of COVID-19, the implementation of the Company’s contract with Carnival Corporation (“Carnival”) had been delayed, although during the third quarter of 2020 Carnival recommenced purchasing activity with the Company making initial deliveries at the end of September 2020. As of October 31,2020, the Company has unfulfilled equipment purchase orders from Carnival amounting to approximately $2,100,000 (in addition to approximately $600,000 of shipments during October 2020). It is anticipated that many of these orders will be fulfilled during the fourth quarter of 2020. Additionally, the operations of some customers in the restaurant and hospitality industries have been temporarily interrupted due to governmental actions. For certain existing restaurant and hospitality customers, the Company has provided a deferral of recurring rental payments for a short time and have modified the rental agreements to extend the term by the period deferred. These actions placed a strain on the Company’s cash flows during the initial wave of COVID-19, resulting in the Company executing on cost controls and cash preservation practices that included reducing executive cash compensation, laying off non-essential employees, limiting expenses and disbursements, as well as extending vendor payments. It is unclear how the second wave that started in October 2020 will impact the Company. During the third quarter of 2020 the Company raised $8,437,480 through an underwritten common stock offering and has subsequently concluded the executive deferred compensation plan and has rehired some of its employees that had been laid off. Basis of Presentation - The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned and controlled subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10‑Q and Article 8 of Regulation S-X. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. It is management’s opinion, however, that the accompanying condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, and the elimination of intercompany accounts and transactions which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying condensed consolidated financial statements should be read in conjunction with the Company’s financial statements for the year ended December 31, 2019, which contains the audited financial statements and notes thereto, for the years ended December 31, 2019 and 2018 included within the Company’s Form 10‑K filed with the Securities and Exchange Commission (“SEC”) on May 22, 2020. The financial information as of December 31, 2019 presented hereto is derived from the audited consolidated financial statements presented in the Company’s audited consolidated financial statements for the year ended December 31, 2019. The interim results for the three and nine months ended September 30, 2020 is not necessarily indicative of the results to be expected for the year ending December 31, 2020 or for any future interim periods. As of September 30, 2020 and December 31, 2019, the Company's active wholly-owned subsidiaries were BioHiTech America, LLC, BioHiTech Europe Limited, BHT Financial, LLC and E.N.A. Renewables LLC, and its controlled subsidiary was Refuel America LLC (60%) and its wholly-owned subsidiaries Apple Valley Waste Technologies Buyer, Inc., Apple Valley Waste Technologies, LLC, New Windsor Resource Recovery LLC and Rensselaer Resource Recovery LLC and its controlled subsidiary Entsorga West Virginia LLC (88.7%). As each of these subsidiaries operate as environmental-based service companies, we did not deem segment reporting necessary. Going Concern and Liquidity - The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These consolidated financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. The ability of the Company to continue as a going concern is dependent on management’s further implementation of the Company’s on-going and strategic plans, which include continuing to raise funds through equity and/or debt raises. Should the Company be unable to raise adequate funds, certain aspects of the on-going and strategic plans may require modification.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2020
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies The condensed consolidated financial statements have been prepared by the Company in accordance with the rules and regulations of the SEC on a consistent basis with and should be read in conjunction with our audited financial statements for the year ended December 31, 2019. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted as permitted by the SEC, although we believe the disclosures that are made are adequate to make the information presented herein not misleading. Recent Accounting Pronouncements: The Company has not implemented any recent accounting pronouncements during the nine months ended September 30, 2020. The Company has not implemented the following accounting standard: In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments . This standard requires an allowance to be recorded for all expected credit losses for certain financial assets. The new standard introduces an approach, based on expected losses, to estimate credit losses on certain types of financial instruments. ASU 2016-13 is effective for public companies for interim and annual period beginning December 15, 2020. Entities are required to apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. The Company has not yet adopted this update and is currently evaluating the effect this new standard will have on its financial condition and results of operations. In March 2020, the FASB issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The amendments in this update provide optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting as the market transitions from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. The amendments in this update were effective upon issuance for all entities through December 31, 2022. The Company is currently evaluating the effect the updated standard will have on its financial position, results of operations or financial statement disclosure. In August 2020, the FASB issued ASU No. 2020-06, Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40). The new guidance eliminates the beneficial conversion and cash conversion accounting models for convertible instruments. It also amends the accounting for certain contracts in an entity’s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation. This guidance is effective as of January 1, 2022 (Early adoption is permitted effective January 1, 2021). The Company is currently evaluating the effect the updated standard will have on its financial position, results of operations or financial statement disclosure. There have been no other recent accounting pronouncements or changes in accounting pronouncements that have been issued but not yet adopted that are of significance, or potential significance, to the Company.

Equipment on Operating Leases,

Equipment on Operating Leases, net	9 Months Ended
	Sep. 30, 2020
Equipment on Operating Leases, net
Equipment on Operating Leases, net	Note 3. Equipment on Operating Leases, net Equipment on operating leases consist of the following: September 30, December 31, 2020 2019 Leased equipment $ 3,126,761 $ 3,138,951 Less: accumulated depreciation (1,709,501) (1,413,953) Total Equipment on Operating Leases, net $ 1,417,260 $ 1,724,998 The Company is a lessor of digester units under non-cancellable operating lease agreements expiring through June 2025. These leases generally have terms of three to five years and do not contain stated extension periods or options for the lessee to purchase the underlying assets. At the end of the leases, the lessee may enter into a new lease or return the asset, which would be available to the Company for releasing. During the three months ended September 30, 2020 and 2019, revenue under the agreements, which is included in rental, service and maintenance revenue, amounted to $356,002 and $369,437, respectively. During the nine months ended September 30, 2020 and 2019, revenue under the agreements, which is included in rental, service and maintenance revenue, amounted to $1,054,534 and $1,061,289, respectively. During the three months ended September 30, 2020 and 2019, depreciation expense amounted to $116,461 and $110,795, respectively. During the nine months ended September 30, 2020 and 2019, depreciation expense amounted to $348,599 and $316,061, respectively. The minimum future estimated contractual payments to be received under these leases as of September 30, 2020 is as follows: Year ending December 31, 2020, remaining period $ 328,885 2021 971,888 2022 705,948 2023 534,345 2024 and thereafter 164,572 $ 2,705,638

HEBioT facility, equipment, fix

HEBioT facility, equipment, fixtures and vehicles, net	9 Months Ended
	Sep. 30, 2020
HEBioT facility, equipment, fixtures and vehicles, net
HEBioT facility, equipment, fixtures and vehicles, net	Note 4. HEBioT facility, equipment, fixtures and vehicles, net HEBioT facility, equipment, fixtures and vehicles, net consist of the following: September 30, December 31, 2020 2019 HEBioT facility $ 31,172,855 $ 31,142,974 HEBioT equipment 7,562,649 7,388,896 Computer software and hardware 115,194 112,629 Furniture and fixtures 48,196 48,196 Vehicles 50,319 50,319 38,949,213 38,743,014 Less: accumulated depreciation and amortization (2,610,486) (1,321,681) Total HEBioT facility, equipment, fixtures and vehicles, net $ 36,338,727 $ 37,421,333

MBT Facility Development and Li

MBT Facility Development and License Costs	9 Months Ended
	Sep. 30, 2020
MBT Facility Development and License Costs
MBT Facility Development and License Costs	Note 5. MBT Facility Development and License Costs MBT Facility Development and License Costs consist of the following: September 30, December 31, 2020 2019 MBT Projects Survey and engineering $ 298,653 $ 235,229 Technology Licenses Future site 6,019,200 6,019,200 Martinsburg, West Virginia, net of $189,000 and $94,500 of amortization as of September 30, 2020 and December 31, 2019 1,701,000 1,795,500 Total Technology Licenses 7,720,200 7,814,700 Total MBT Facility Development and License Costs $ 8,018,853 $ 8,049,929 MBT Facility Development Costs – During 2018, the Company commenced initial development of a project in Rensselaer, NY. As of June 30, 2020, the Company has received local permits and has filed the required state permit applications, which are undergoing review by the New York State Department of Environmental Conservation (“NYSDEC”). On August 10, 2020 the NYSDEC, by letter, informed the Company that the application had been initially denied. The Company disagrees with this decision, and as is part of the process, has exercised its right to appeal the NYSDEC findings. Technology License Agreement – Future Facility – The royalty payment for the license amounted to $6,019,200. This Technology License Agreement can be utilized at a future project and will be amortized once the facility is in operation. Technology License Agreement – Martinsburg, West Virginia – In connection with the 2018 acquisition accounting applied to Entsorga West Virginia acquisition, the License Agreement was valued at $1,890,000. During the three and nine months ending September 30, 2020 amortization amounted to $31,500 and $94,500, respectively. During the three and nine months ending September 30, 2019 amortization amounted to $31,500 and $63,000, respectively. Amortization of the License Agreement commenced with the facility becoming operational on March 31, 2019 and there was no amortization for the three months ended March 31, 2019.

Line of Credit, Promissory Note

Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts	9 Months Ended
	Sep. 30, 2020
Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts
Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts	Note 6. Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts consist of the following: September 30, 2020 December 31, 2019 Related Related Total Party Total Party Line of credit $ 1,497,950 $ — $ 1,479,848 $ — Senior secured promissory note 4,408,514 — 4,160,490 — Junior promissory note 965,881 965,881 949,434 949,434 Note payable under Payroll Protection Program 421,300 — — — Note payable 100,000 — 100,000 — Advances from related parties (See Note 14 Related Parties) 935,000 935,000 210,000 210,000 Long term debt - current and long-term portion 9,262 — 12,806 — Line of Credit — The Credit Agreement and Note with Comerica does not have any financial covenants, carries interest at the rate of 3%, plus either the Comerica prime rate or a LIBOR-based rate, (5.00% and 5.71% (total interest rate) as of September 30, 2020 and December 31, 2019, respectively) which was amended on June 30, 2020 as a demand note with an interest rate of 3%, plus a LIBOR-based rate (with a floor of 1%). The line of credit is secured by the assets of BHT Financial, LLC and is personally guaranteed by the Company’s Chairman of the Board and former Chief Executive Officer, Frank E. Celli, and James D. Chambers, a director. Michaelson Senior Secured Term Promissory Financing –Company and several of the Company’s wholly-owned subsidiaries have a Note Purchase and Security Agreement with Michaelson Capital Special Finance Fund II, L.P. (“ MCSFF ”) for a senior secured term promissory note in the principal amount of $5,000,000 (the “Note”). The Note is not convertible and accrues interest at the rate of 10.25% per annum. While the Company had not met certain of its senior secured note’s financial covenants as of September 30, 2020, the Company has received a waiver for such non-compliance through September 30, 2020. Despite its current compliance under the waiver, until such time as the Company regains compliance or receives a waiver of such covenants for a year beyond the balance sheet date, under current GAAP accounting rules the senior secured notes amounting to $4,408,514 have been classified as current debt. As of December 31, 2019 those certain financial covenants were not met and a waiver of such was granted by MCSFF through January 1, 2021 with the condition that the parties negotiate new financial covenants, which were concluded on June 29, 2020. As of December 31, 2019, the Note has been classified based on the contractual repayment schedule. For purposes of the following maturity schedule, as the Company believes that it will achieve compliance with the revised financial covenants and MCSFF has a history of waiving non-compliance with financial covenants, the maturities have been presented based upon the contractual repayment terms in effect as of September 30, 2020. The Note is contractually scheduled to be repaid in eight, equal, quarterly installments of $625,000 commencing on May 15, 2021 and ending February 2, 2023 (the “Maturity Date”). Note Payable under Payroll Protection Program - On May 13, 2020 BioHiTech America, LLC, a subsidiary of the Company, was funded $421,300 under the Payroll Protection Program ("PPP") through Comerica Bank. The PPP was established as part of the Coronavirus Aid, Relief and Economic Security Act (the "CARES Act") and is administered by the U.S. Small Business Administration. The PPP Loan is non-collateralized and has no guarantees, has a two-year term and bears interest at an annual interest rate of 1%. Monthly principal and interest payments are deferred for six months, and the maturity date is May 13, 2022. Under the terms of the CARES Act, PPP loan recipients can apply for and be granted forgiveness for all or a portion of the loan granted under the PPP. Such forgiveness will be determined, subject to limitations, based on the use of loan proceeds for payment of payroll costs and any payments of mortgage interest, rent, and utilities. However, no assurance is provided that forgiveness for any portion of the PPP Loan will be obtained. Note Payable - As of September 30, 2020 and December 31, 2019, the $100,000 note, which was amended on July 27, 2020, carries interest at 10% and matures on January 1, 2022. Contractual Maturities of Senior Secured, Junior Promissory, Notes Payable and Long Term Debt — As of September 30, 2020, excluding discounts and deferred finance costs, which are being amortized as interest expense, are as follow: Non- Year Ending December 31, Amortizing Amortizing Total 2020 (Remaining) $ 1,061 $ 23,406 $ 24,467 2021 4,380 2,155,866 2,160,246 2022 3,821 2,717,028 2,720,849 2023 — 625,000 625,000 2024 and thereafter — 1,044,477 1,044,477 Total $ 9,262 $ 6,565,777 $ 6,575,039

Entsorga West Virginia, LLC WVE

Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds	9 Months Ended
	Sep. 30, 2020
Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds
Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds	Note 7. Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds During 2016, Entsorga West Virginia LLC (the “Borrower”) was issued $25,000,000 in Non-Recourse Solid Waste Revenue Bonds from the West Virginia Economic Development Authority (the “WVEDA Bonds”). The WVEDA Bonds were issued in two series with one for $7,535,000 bearing interest at 6.75% per annum with a maturity date of February 1, 2026 and the second for $17,465,000 bearing interest at 7.25% per annum with a maturity of February 1, 2036. Both series were issued at par. The 2026 series was payable with interest-only payments through February 1, 2019 then annual payments of principal and semi-annual payments of interest through maturity. The 2036 series is payable with interest-only payments through February 1, 2019 then annual payments of principal and semi-annual payments of interest through maturity. Repayment of principal is by way of sinking fund. During 2018, the 2016 Indenture Trust and Loan Agreement were amended and restated effective November 1, 2018. These amendments provided for a third series of bonds amounting to $8,000,000 bearing interest at 8.75% per annum with a maturity date of February 1, 2036, with special event triggered pre-payment requirements. This series was issued at par. The 2036 series is payable with interest-only payments through February 1, 2020 then annual payments of principal and semi-annual payments of interest through maturity. Repayment is by way of sinking fund. The outstanding balance of the WVEDA Bonds as of September 30, 2020 and December 31, 2019 is $33,000,000, which is presented net of unamortized debt issuance costs amounting to $2,207,759 as of September 30, 2020 and December 31, 2019, less associated amortization of $516,243 and $415,185 as of September 30, 2020 and December 31, 2019, respectively, which includes amortization prior to the Company’s control acquisition in 2018. Amortization is calculated on the effective interest method, which is included in interest expense in the accompanying consolidated statements of operations and comprehensive loss. The loan agreement and indenture of trust place restrictions on the Borrower and its members regarding additional encumbrances on the property, disposition of the property, and limitations on equity distributions. The loan agreement also provides for financial covenants, which became effective on September 30, 2019. As of September 30, 2020 and December 31, 2019 the Company was not in compliance with all of the financial covenants and subsequently was in default on a principal repayment due in February 2020 and has entered into a forbearance agreement with the bond trustee that provides, they will not accelerate the repayment of the bonds due to the defaults through October 2, 2021. The future sinking fund payments by the Borrower as of September 30, 2020 are as follow: 2016 Issue 2016 Issue 2018 Issue Year Ending December 31, 2026 Series 2036 Series 2036 Series Total 2020 (remaining) $ 1,160,000 $ — $ 230,000 $ 1,390,000 2021 1,215,000 — 255,000 1,470,000 2022 900,000 — 275,000 1,175,000 2023 965,000 — 300,000 1,265,000 2024 and thereafter 3,295,000 17,465,000 6,940,000 27,700,000 Total $ 7,535,000 $ 17,465,000 $ 8,000,000 $ 33,000,000

Equity and Equity Transactions

Equity and Equity Transactions	9 Months Ended
	Sep. 30, 2020
Equity and Equity Transactions
Equity and Equity Transactions	Note 8. The Company has 50,000,000 shares of its $0.0001 par common stock and 10,000,000 shares of blank check preferred stock authorized by its shareholders. As of September 30, 2020 and December 31, 2019, 23,354,130 and 17,300,899 shares of common stock have been issued; and 3,209,210 and 3,179,120 shares, respectively, of preferred stock have been designated in five series of shares, which have a total of $1,602,675 in accumulated, but undeclared preferential dividends as of September 30, 2020, as follows: Designated Par Stated Shares Outstanding Designation Shares Value Value September 30, 2020 December 31, 2019 Series A Convertible Preferred Stock 333,401 $ 0.0001 $ 5.00 125,312 145,312 Series B Convertible Preferred Stock 1,111,200 0.0001 $ 5.00 — — Series C Convertible Preferred Stock 1,000,000 0.0001 $ 10.00 427,500 427,500 Series D Convertible Preferred Stock 20,000 0.0001 $ 100.00 17,350 18,850 Series E Convertible Preferred Stock 714,519 0.0001 $ 2.64 264,519 264,519 Series F Convertible Preferred Stock 30,090 0.0001 $ 115.00 13,611 — Under the terms of the Company’s senior lender agreements, the Company is restricted from paying dividends in cash, but is allowed to pay dividends in common stock. The Company, since its merger in 2015, has not paid any cash or stock dividends on common stock. The consolidated financial statements include less than 100% owned and controlled subsidiaries and include equity attributable to non-controlling interests that take the form of the underlying legal structures of the less than 100% owned subsidiaries. Entsorga West Virginia LLC through its limited liability agreement and the agreements related to its WVEDA Bonds have restrictions on distributions to and loans to owners while the WVEDA Bonds are outstanding. Common Stock Underwritten Offering – On July 27, 2020, BioHiTech Global, Inc. entered into an underwriting agreement (the “Underwriting Agreement”) with Maxim Group LLC (“Maxim”), as representative of certain underwriters (the “Underwriters”). Pursuant to the terms and conditions of the Underwriting Agreement, The Company agreed to issue and sell 4,550,000 shares of our common stock, par value $0.0001 per share (the “Underwritten Shares”), at a price to the public of $1.81 per share. Pursuant to the Underwriting Agreement, the Company also granted the underwriter an option to purchase up to an additional 682,500 shares of the Company’s common stock (together with the Underwritten Shares, the “Shares”) within 45 days after the date of the Underwriting Agreement to cover over-allotments, if any. The offering was consummated on July 29, 2020. The Underwriters received underwriting commissions of 9% for $741,195, plus reimbursement of counsel fees in the amount of $65,000. Maxim acted as the lead book-running manager for the offering and Spartan Capital Securities, LLC acted as co-book-runner for the offering. In addition, the Company agreed to issue warrants to purchase 318,666 shares of our Common Stock to the Underwriters (the “Underwriters’ Warrants”), as a portion of the underwriting compensation payable to the underwriters in connection with this offering. The Underwriters’ Warrants are exercisable for a period commencing 180 days following the closing of the offering and ending on the fifth anniversary of the closing date at an exercise price equal to $1.991 per share, or 110% of the offering price of the common stock. The Company agreed to grant the Underwriters piggy-back registration rights for five (5) years in the event we file certain registration statements for the registration of other shares of Common Stock. On August 11, 2020 the underwriter provided notice that they would be exercising their over-allotment provision of the Underwriting Agreement to purchase an additional 682,500 shares of the Company’s common stock at $1.81 per share for a gross purchase price of $1,235,325. The net proceeds to the Company, after underwriter’s commission and before other costs amount $1,124,146. This transaction was consummated on August 13, 2020. The net proceeds to the Company from the offering were: Gross proceeds at $1.81 per share $ 9,470,825 Less: Underwriters’ fees (852,374) Legal fees (139,033) Accounting fees (30,900) Filing and other fees (11,038) Net proceeds to the Company $ 8,437,480 Other Common Stock Activity – Other than conversions of preferred stock and preferred stock dividends and the drawdown of vested restricted stock units, during the third quarter of 2020, the Company issued 141,259 shares of common stock, at market, to vendors and creditors in place of cash payments as part of its cash conservation practices resulting from the COVID-19 outbreak. Series A Redeemable Convertible Preferred Stock – On July 30, 2020 a Series A Redeemable Convertible Preferred Stock (“Sr. A PS”) holder converted, in accordance with the terms of the Sr. A PS, 20,000 shares of Sr. A PS into 55,556 shares of the Company’s common stock. In connection with the conversion, the holder was also paid accrued dividends on the Sr. A PS through the conversion date amounting to $7,350 through the issuance of 4,083 shares of the Company’s common stock. Series D Convertible Preferred Stock – On July 13, 2020, a Series D Convertible Preferred Stock (“Sr. D PS”) holder converted, in accordance with the terms of the Sr. D PS, 1,500 shares of Sr D PS into 83,334 shares of the Company’s common stock. In connection with the conversion, the holder was also paid accumulated dividends on the Sr. D PS through the conversion date amounting to $14,388 through the issuance of 7,994 shares of the Company’s common stock. In July 2020, two separate holders of the Sr D PS requested, in accordance with the terms of the Sr D PS, that accumulated dividends amounting to $17,840 be paid in 9,912 shares of the Company’s common stock, which was issued on July 21, 2020. Series F Convertible Preferred Stock – On March 9, 2020 the Company designated a new series of preferred stock and subsequently on March 18, 2020 had an initial closing of $1,500,000 on 13,045 shares of the new series of preferred stock and 178,597 five-year common stock warrants at $2.30 per share and are presented net of $50,836 in warrant valuations and $4,550 in issuance costs. On April 6, 2020 had an additional closing of $65,000 on 566 shares of the new series of preferred stock and 7,750 five-year common stock warrants at $2.30 per share and are presented net of $2,205 in warrant valuations. The newly designated series, the Series F Redeemable, Convertible Preferred Stock (the “Sr. F Preferred Stock”) is comprised of 30,090 shares with a par value of $0.0001 per share and a stated value per share of $115.00 that has a dividend rate of 9%. The Sr. F Preferred Stock is convertible by the holder at any time at a conversion rate of $2.10 as of the issuance of the Sr. F Preferred Stock, $1.81 as of July 27, 2020 as the result of the common stock offering, subject to certain antidilution adjustments and is redeemable by the Company after 24 months at its stated value, plus any outstanding accrued or accumulated dividends for cash, or if the Company’s common stock is trading over $3.00 per share and has daily trading volume of over 50,000 shares, for the Company’s common stock at the conversion rate in effect at the time. Warrants – In connection with the issuance of convertible debt, preferred and common stock and in connection with services provided, the Company has warrants to acquire 4,676,361 shares of the Company’s common stock outstanding as of September 30, 2020, as follows: Weighted Average Expiring During the Year Warrant Exercise Price Exercises Price Ending December 31, Shares per Share per Share 2021 1,701,827 $3.30 - $3.75 $ 2022 1,253,149 $1.80 - $5.00 $ 2023 740,749 $1.80 $ 2024 269,293 $1.80 $ 2025 711,343 $1.80 - $2.25 $ The following table summarizes the outstanding warrant activity for the nine months ended September 30, 2020: Outstanding, January 1, 2020 4,674,261 Issued as a result of Series F Convertible Preferred Stock offering 186,347 Issued to common stock offering underwriters 318,666 Issued to professional services providers 150,000 Exercised (630,053) Expired (22,860) Outstanding, September 30, 2020 4,676,361 On June 30, 2020, one holder of 630,053 warrants with an exercise price of $1.80 per share exercised in a cashless exercise all of their warrants in exchange for 372,304 shares of the Company’s common stock. On July 13, 2020 the Company issued a total of 150,000 warrants to several professional service providers. The warrants have an exercise price of $1.80 per share and expire in five years. The warrants were valued utilizing the Black-Scholes option pricing model with the following assumptions: risk-free interest rate of 0.3%, expected dividend yield of 0%, expected volatility of 55.6% and term of 5 years On July 27, 2020 as a result of the underwritten offering of common stock at $1.81 per share, the warrant exercise price of the warrants issued in connection with the Sr. F Preferred Stock was reduced from $2.30 to $1.81. As a result of the down deal feature the revaluation of the warrants, which amounted to $21,738, has been reflected as a deemed dividend.

Equity Incentive Plans

Equity Incentive Plans	9 Months Ended
	Sep. 30, 2020
Equity Incentive Plans
Equity Incentive Plans	Note 9. Equity Incentive Plans The Company has two shareholder approved equity incentive plans: 2015 Equity Incentive Plan — During 2015, the Company established the BioHiTech Global, Inc. 2015 Equity Incentive Plan, which is available to eligible employees, directors, consultants and advisors of the Company and its affiliates. The plan allows for the granting of incentive stock options, nonqualified stock options, reload options, stock appreciation rights, and restricted stock representing up to 750,000 shares. The Plan is administered by the Compensation Committee of the Board of Directors. On July 23, 2020 the shareholders of the Company approved a 500,000 increase in the plan’s shares, increasing the plan’s shares to 1,250,000. 2017 Executive Incentive Plan — During 2017, the shareholders approved the 2017 Executive Incentive Plan, which is available to eligible employees, directors, consultants and advisors of the Company and its affiliates. The plan allows for the granting of incentive stock options, nonqualified stock options, reload options, stock appreciation rights, and restricted stock representing up to 1,000,000 shares. The Plan is administered by the Compensation Committee of the Board of Directors. On July 23, 2020 the shareholders of the Company approved a 500,000 increase in the plan’s shares, increasing the plan’s shares to 1,500,000. Effective January 30, 2020, the Company granted nonqualified options for 155,450 shares and 269,060 restricted stock units. The options granted had a fair value of $162,959 using the Black-Scholes option pricing model with the following assumptions: risk-free interest rate of 1.44%, expected dividend yield of 0%, expected volatility of 49.24% and expected term in years of from 1.00 to 2.92 years. The restricted stock units had a value of $538,120 based on the market value on the date of the grants and a weighted average vesting period of 0.75 years. Effective September 19, 2020, the Company granted 136,145 restricted stock units under the Interim Executive Plan. The restricted stock units had a value of $174,266 based on the market value on the date of the grants and immediately vested. Compensation expense related to stock options and restricted stock was: Three months ended September 30, Nine months ended September 30, 2020 2019 2020 2019 Stock options $ 34,605 $ 31,323 $ 124,383 $ 104,075 Restricted stock 438,042 178,262 940,886 637,113 Total $ 472,647 $ 209,585 $ 1,065,269 $ 741,188 Compensation expense related to stock options and restricted stock for are reflected in the following captions within operating expenses in the condensed consolidated statements of operations and comprehensive loss: Three months ended September 30, Nine months ended September 30, 2020 2019 2020 2019 Rental, service and maintenance $ 2,097 $ 3,353 $ 8,416 $ 12,426 Selling, general and administrative 470,550 206,232 1,056,853 728,762 Total $ 472,647 $ 209,585 $ 1,065,269 $ 741,188 The following summarizes the Company’s stock option activity for the nine months ended September 30, 2020: Weighted Average Weighted Remaining Average Contractual Number of Exercise Life Aggregate Options Price (in Years) Intrinsic Value Outstanding – January 1, 2020 363,826 $ 3.71 — Granted 155,450 — — Exercised — — — — Forfeited, Canceled or Expired (58,417) — — Outstanding – September 30, 2020 460,859 3.16 — Exercisable – September 30, 2020 307,021 3.49 — The following summarizes the Company’s restricted stock unit activity for the nine months ended September 30, 2020: Balance, January 1, 2020 291,730 Grants 405,205 Forfeited — Vested (403,233) Balance, September 30, 2020 293,702 As of September 30, 2020, 804,221 restricted stock units have been vested but not yet drawn down by the grantees. Interim Executive Plan - During the second quarter of 2020, the Company established a payroll cash deferment program in order to improve cash resources during the COVID-19 pandemic. Under the program, certain executives reduced their cash compensation and would be provided restricted common stock units under the shareholder approved plans as the shares were available or may be issued restricted common stock shares or cash. The shares under the individual agreements were based on a cash amount of deferral each month divided by the lower of the average or last trading day common share price. Under the program that has been concluded, all of the participants elected to receive restricted stock units resulting in 136,145 restricted stock units being issued at a cost of $174,266 that has been reflected as restricted stock compensation expense above.

Revenue

Revenue	9 Months Ended
	Sep. 30, 2020
Revenue
Revenue	Note 10. Revenue The Company recognizes revenue as services are performed or products are delivered and generally recognize revenue for the gross amount of consideration received as we are generally the primary obligor (or principal) in our contracts with customers as we hold complete responsibility to the customer for contract fulfillment. We record amounts collected from customers for sales tax on a net basis. Disaggregation of Revenue — The disaggregation of revenue is as follows: Three months ended September 30, Nine months ended September 30, 2020 2019 2020 2019 Revenue Type: Rental of digesters $ 356,001 $ 369,438 $ 1,054,534 $ 1,061,289 Services 250,177 960,146 1,428,017 1,929,174 Product sales 136,699 97,191 893,599 222,226 Total $ 742,877 $ 1,426,775 $ 3,376,150 $ 3,212,689

Risk Concentrations

Risk Concentrations	9 Months Ended
	Sep. 30, 2020
Risk Concentrations
Risk Concentrations	Note 11. Risk Concentrations The Company operates as a single segment on a worldwide basis through its subsidiaries, resellers and independent sales agents. Gross revenues and net non-current tangible assets on a domestic and international basis are as follows: United States International Total 2020: Revenue, for the nine months ended September 30, 2020 $ 3,079,083 $ 297,067 $ 3,376,150 Revenue, for the three months ended September 30, 2020 631,450 111,427 742,877 Non-current tangible assets, as of September 30, 2020 37,469,194 295,293 37,764,487 2019: Revenue, for the nine months ended September 30, 2019 $ 2,877,157 $ 335,532 $ 3,212,689 Revenue, for the three months ended September 30, 2019 1,333,878 92,897 1,426,775 Non-current tangible assets, as of December 31, 2019 38,803,833 355,825 39,159,658 Credit risk — Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and accounts receivable. The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institutions. At times, the Company’s cash may be uninsured or in deposit accounts that exceed the Federal Deposit Insurance Corporation (“FDIC”) in the USA and the Financial Conduct Authority (“FCA”) in the UK insurance limits. Through September 30, 2020, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Major customers — During the three months ended September 30, 2020, two customers represented at least 10% of revenues, accounting for 18.9% (Gold Medal Group, LLC, an affiliated entity, “GMG” or “Gold Medal”) and 45.1% of revenues. During the three months ended September 30, 2019, one customer represented at least 10% of revenues, accounting for 58.9% (Gold Medal Group, LLC, an affiliated entity, “GMG”) of revenues. During the nine months ended September 30, 2020, two customers represented at least 10% of revenues, 32.5% (GMG) and 11.4% of revenues. During the nine months ended September 30, 2019, one customer represented at least 10% of revenues, 49.2% (GMG) of revenues. As of September 30, 2020, three customers represented at least 10% of accounts receivable, accounting for 63.4% (GMG),18.6% and 11.5% of accounts receivable. As of December 31, 2019 one customer represented at least 10% of accounts receivable, accounting for 58.9% (GMG) of accounts receivable. Vendor concentration — During the three months ended September 30, 2020, one vendor represented at least 10% of costs of revenue, accounting for 14.2% (GMG). During the three months ended September 30, 2019, two vendors represented at least 10% of costs of revenue, accounting for 21.5% (GMG) and 18.9% (a 1.2% shareholder). During the nine months ended September 30, 2020, one vendor represented at least 10% of costs of revenue, accounting for 26.1% (GMG). During the nine months ended September 30, 2019, two vendors represented at least 10% of costs of revenue, accounting for 11.9% (GMG) and 16.3% (a 1.2% shareholder). As of September 30, 2020, excluding construction payables and other professional fees, one vendor represented at least 10% of accounts payable accounting for 31.8% (GMG) of accounts payable. As of December 31, 2019, one vendor represented at least 10% of accounts payable accounting for 54.4% (GMG) of accounts payable. Affiliate relationship — GMG owns a 40% interest in Refuel America, LLC, a consolidated subsidiary of the Company. GMG’s subsidiaries, which are not consolidated in the Company’s financial statements have several business relationships with the Company and its subsidiaries that result in revenues and expenses noted above. See Note 14. Related Party Transactions.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies
Commitments and Contingencies	Note 12. Commitments and Contingencies During the nine months ended September 30, 2020 the Company was involved in the following legal matters. During September 2020, the Company’s Entsorga West Virginia subsidiary received notice that an affiliate of a minority owner of the facility, who also provided intellectual property, equipment and engineering services relating to the set-up and initial operation of the facility, was claiming it was owed $917,420 related to services contracted as part of the facility’s construction and initial start-up and operation. The Company incurred offsetting costs and expenses greater than the claim correcting or replacing the services that were contracted but that were either not performed or performed correctly. No action has been commenced related to this claim and the Company disputes the claim and intends to defend this matter vigorously. As a result of this claim and the related costs incurred by the Company to cure the deficiencies in the services that were contracted, the Company has reflected an impairment charge amounting to $917,420 during the three and nine months ended September 30, 2020. On February 7, 2018, Lemartec Corporation (“Lemartec”) filed a complaint against the Company in the United States District Court for the Northern District of West Virginia arising out of the construction of the Company’s resource recovery facility in Martinsburg, West Virginia alleging breach of contract and unjust enrichment. The Company has filed its answer and counterclaims for damages against Lemartec and cross claims against Lemartec’s performance bond surety, Philadelphia Indemnity Insurance Company. The trial was scheduled to begin in August 2020. Prior to the start of the trial, on March 12, 2020 the Company entered into a settlement agreement that detailed the full and final mutual release. The settlement agreement provides that the Company pay Lemartec $775,000 in installments of $475,000 within 60 days of the execution of the settlement agreement and $25,000 each month thereafter for 12 months. The Company’s consolidated financial statements as of December 31, 2019 reflects this liability given the nature of the subsequent event. It is management’s opinion that the resolution of these matters will not materially affect the Company’s future financial position, results of operations, or cash flows. From time to time, the Company may be involved in other legal matters arising in the ordinary course of business. While the Company believes that such matters are currently not material, there can be no assurance that matters arising in the ordinary course of business for which the Company is, or could be, involved in litigation, will not have a material adverse effect on its business, financial condition or results of operations

Leases

Leases	9 Months Ended
	Sep. 30, 2020
Leases
Leases	Note 13. Leases The Company rented its headquarters and attached warehousing space from a related party through May 31, 2020 (see Note 14), effective June 1, 2020 the property housing the Company’s headquarters and attached warehousing space was sold to an unrelated party, and has a land lease relating to the Martinsburg, WV HEBioT facility under operating leases. The HEBioT facility land lease has an initial term of 30 years, plus four 5‑year extensions. For purposes of our determination of lease liabilities, extensions were not included. As the leases do not provide an implicit rate, the Company used incremental borrowing rates in determining the present value of lease payments. For the HEBioT facility land lease a rate of 11% was utilized and a rate of 10.25% has been used on the other leases. The current portion of the lease liabilities of $207,515 is included in accrued expenses and liabilities. Total lease costs under operating leases amounted to $57,129 and $55,356 for the three months, and $167,841 and $166,067 for the nine months ended September 30, 2020 and 2019, respectively. Maturities of lease liabilities under these leases, which have a weighted average remaining term of 19.7 years, as of September 30, 2020 is: Year Ending December 31, 2020 (remaining) $ 51,783 2021 212,026 2022 217,571 2023 219,140 2024 and thereafter 3,133,649 Total lease payments 3,834,169 Less imputed interest (2,419,658) Present value of lease liabilities $ 1,414,511 During the nine months ended September 30, 2020, the Company recognized operating lease right of use assets in exchange for lease liabilities amounting to $412,647 and had operating cash flows of $51,783 and $51,406 for the three months, and $140,837 and $143,597 for the nine months ended September 30, 2020 and 2019, respectively.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2020
Related Party Transactions
Related Party Transactions	Note 14. Related Party Transactions Related parties include Directors, Senior Management Officers, and shareholders, plus their immediate family, who own a 5% or greater ownership interest at the time of a transaction. Related parties also include GMG and its subsidiaries as a result of its 40% interest in Refuel America, LLC ("Refuel"), a consolidated entity of the Company. During 2018 GMG acquired as regional waste management entity, Apple Valley Waste (“AVW”), with operations located in West Virginia, Maryland and Pennsylvania. As part of this acquisition, GMG also acquired AVW's interests in EWV that were contributed to Refuel. Prior to GMG’s acquisition of AVW and the Company’s investments and control acquisition of EWV, in order for EWV to receive the proceeds from the Entsorga West Virginia, LLC WVEDA Non-Recourse Solid Waste Disposal Revenue Bonds , EWV and AWV had entered into several agreements relating to business services, solid waste delivery and disposal. The table below presents the face amount of direct related party assets and liabilities and other transactions or conditions as of or during the periods indicated. September 30, December 31, 2020 2019 Assets: Accounts receivable (a) (b) $ 2,227,224 $ 1,370,867 Intangible assets, net, included in other assets (c) 25,249 40,399 Liabilities: Accounts payable (c) (d) (e) (f) 3,851,722 2,531,034 Accrued interest payable 165,396 46,796 Long term accrued interest (g) 1,729,605 1,510,193 Advance from related party (h) 935,000 210,000 Junior promissory note (g) 965,881 949,434 Other: Line of credit guarantee (i) 1,497,950 1,479,848 The table below presents direct related party expenses or transactions for the three and nine months ended September 30, 2020 and 2019. Compensation and related costs for employees of the Company are excluded from the table below. Three months ended September 30, Nine months ended September 30, 2020 2019 2020 2019 Management advisory and other fees (a) $ 25,000 $ 250,000 $ 125,000 $ 750,000 HEBioT revenue (b) 115,173 590,262 970,943 831,274 Operating expenses - HEBioT (d) 178,545 210,709 952,931 354,733 Operating expenses - Selling, general and administrative (e) — 24,537 41,514 73,611 Operating expenses - Selling, general and administrative (c) (f) 110,650 110,650 332,016 258,050 Interest expense 98,571 76,611 295,592 194,266 Debt guarantee fees (i) 16,875 16,875 50,625 50,625 Summary notes: a - Management Advisory Fees f - Business Services Fees b - HEBioT Disposal Revenues g - Junior Promissory Note c - Distribution Agreement h - Advances from Related Parties d - Disposal costs i - Line of Credit e - Facility Lease Advances from Related Parties - The Company’s Chief Executive Officer (the “Officer”) on occasion advances the Company funds for operating and capital purposes. The advances bear interest at 13% and are unsecured and due on demand. There are no financial covenants related to this advance and there are no formal commitments to extend any further advances. In addition, during the three months ended March 31, 2020 another officer advanced $200,000 to the Company which was repaid during the three months ended June 30, 2020. Claims by Related Party - During September 2020, the Company’s Entsorga West Virginia subsidiary received notice that a minority owner of the facility, who also provided intellectual property, equipment and engineering services relating to the set-up and initial operation of the facility, was claiming $917,420 related to services contracted as part of the facility’s construction and initial start-up and operation. The Company incurred offsetting costs and expenses greater than the claim correcting or replacing the services that were contracted but that were either not performed or performed correctly and intends to defend this matter vigorously. As a result of this claim and the related costs incurred by the Company to cure the deficiencies in the services that were contracted, the Company has reflected an impairment charge amounting to $917,420 during the third quarter of 2020.

Supplemental Consolidated State

Supplemental Consolidated Statement of Cash Flows Information	9 Months Ended
	Sep. 30, 2020
Supplemental Consolidated Statement of Cash Flows Information
Supplemental Consolidated Statement of Cash Flows Information	Note 15. Supplemental Consolidated Statement of Cash Flows Information Changes in non-cash operating assets and liabilities, as well as other supplemental cash flow disclosures, are as follows. Nine Months Ended September 30, 2020 2019 Changes in operating assets and liabilities: Accounts receivable $ (1,302,729) $ (1,335,024) Inventory (210,886) (181,979) Prepaid expenses and other assets (94,156) (3,300) Accounts payable 1,149,030 3,111,285 Accrued interest payable (322,753) (260,046) Accrued expenses (843,188) (2,504,724) Deferred revenue 6,921 (1,131) Customer deposits 708,254 37,109 Net change in operating assets and liabilities $ (909,507) $ (1,137,810) Supplementary cash flow information: Cash paid during the periods for: Interest $ 1,596,332 $ 2,625,018 Income taxes — — Supplementary Disclosure of Non-Cash Investing and Financing Activities: Transfer of inventory to leased equipment $ 84,501 $ 259,449 Accrual of Series A preferred stock dividends 52,654 140,631 Conversion of preferred stock into common 239,566 90,000 Payment of preferred stock dividends in common stock 21,732 50,000 Acquisition of right of use leased asset and creation of lease liability 412,647 — Reconciliation of Cash and Restricted Cash: Cash $ 4,950,112 $ 3,434,089 Restricted cash (current) 1,287,138 1,128,716 Restricted cash (non-current) 2,646,448 2,544,948 Total cash and restricted cash at the end of the period $ 8,883,698 $ 7,107,753

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2020
Subsequent Events
Subsequent Events	Note 16. Subsequent Events The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements are available to be issued. Any material events that occur between the balance sheet date and the date that the financial statements were available for issuance are disclosed as subsequent events, while the financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, except as disclosed within the footnotes or as discussed below, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements. On October 19, 2020, the Company entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) to purchase 49% of newly-issued membership interests (the “Interests”) of East Shore Port Ventures, LLC, a New York limited liability company (“East Shore”). Pursuant to the Purchase Agreement, the Company purchased the Interests in consideration for $650,000 to East Shore and warrants (the “Warrants”) to purchase an aggregate of 100,000 shares of the Company’s common stock, par value $0.0001 per share issued to East Shore’s existing members. The Purchase Agreement contains customary provisions, including representations, warranties, and indemnities, and closed upon the satisfaction of customary closing conditions.

Condensed Consolidating Financi

Condensed Consolidating Financial Information	9 Months Ended
	Sep. 30, 2020
Condensed Consolidating Financial Information
Condensed Consolidating Financial Information	Note 17. Condensed Consolidating Financial Information The WVEDA Solid Waste Disposal Revenue Bond obligations of Entsorga West Virginia LLC are not guaranteed by its members, including the Company, however the membership interests of Entsorga West Virginia LLC are pledged, and the debt agreements provide restrictions prohibiting distributions to the members, including equity distributions or providing loans or advances to the members. The following pages present the Company’s condensed consolidating balance sheet as of September 30, 2020 and December 31, 2019, the condensed consolidating statements of operations for the three and nine months ended September 30, 2020 and 2019, and condensed consolidating cash flows for the nine months ended September 30, 2020 and 2019 of Entsorga West Virginia LLC and the Parent consolidated with other Company subsidiaries not subject to the WVEDA Solid Waste Disposal Revenue Bond restrictions and the elimination entries necessary to present the Company’s financial statements on a consolidated basis. The following condensed consolidating financial information should be read in conjunction with the Company’s consolidated financial statements. Condensed Consolidating Balance Sheet as of September 30, 2020 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Assets Cash $ 4,948,342 $ 1,770 $ — $ 4,950,112 Restricted cash — 1,287,138 — 1,287,138 Other current assets 2,085,508 2,094,211 — 4,179,719 Current assets 7,033,850 3,383,119 — 10,416,969 Restricted cash — 2,646,448 — 2,646,448 HEBioT facility and other fixed assets 1,438,255 36,317,732 — 37,755,987 Operating lease right of use assets 396,562 888,730 — 1,285,292 MBT facility development and license costs 6,317,853 1,701,000 — 8,018,853 Investment in subsidiaries and intercompany accounts 16,444,214 — (16,444,214) — Goodwill — 58,000 — 58,000 Other assets 33,749 — — 33,749 Total assets $ 31,664,483 $ 44,995,029 $ (16,442,214) $ 60,215,298 Liabilities and stockholders’ equity Line of credit $ 1,497,950 $ — $ — $ 1,497,950 Current portion of Debts and Bonds 4,670,301 2,860,000 — 7,530,301 Other current liabilities 3,716,174 13,081,770 (5,948,711) 10,849,233 Current liabilities 9,884,425 15,941,770 (5,948,711) 19,877,484 Notes payable and other debts 1,234,656 — — 1,234,656 Accrued interest 1,729,605 — — 1,729,605 Non-current lease liabilities 286,314 944,830 — 1,231,144 WV EDA bonds — 28,448,484 — 28,448,484 Total liabilities 13,135,000 45,335,084 (5,948,711) 52,521,373 Redeemable preferred stock 626,553 — — 626,553 Stockholders' equity: Attributable to parent 15,748,136 (340,055) (10,495,503) 4,912,578 Attributable to non-controlling interests 2,154,794 — — 2,154,794 Stockholders’ equity 17,902,930 (340,055) (10,495,503) 7,067,372 Total liabilities and stockholders’ equity $ 31,664,483 $ 44,995,029 $ (16,444,214) $ 60,215,298 Condensed Consolidating Statement of Operations for the three months ended September 30, 2020 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Revenue $ 742,252 $ 625 $ — $ 742,877 Operating expenses HEBioT — 945,810 — 945,810 Rental, service and maintenance expense 139,665 — — 139,665 Equipment 171,002 — — 171,002 Selling, general and administrative 1,430,095 494,198 — 1,924,293 Impairment expense — 917,420 — 917,420 Depreciation and amortization 124,759 437,384 — 562,143 Total operating expenses 1,865,521 2,794,812 — 4,660,333 Loss from operations (1,123,269) (2,794,187) — (3,917,456) Other (income) expenses, net 336,749 686,308 — 1,023,057 Net loss $ (1,460,018) $ (3,480,495) $ — $ (4,940,513) Condensed Consolidating Statement of Operations for the nine months ended September 30, 2020 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Revenue $ 1,992,494 $ 1,383,656 $ — $ 3,376,150 Operating expenses HEBioT — 2,778,514 — 2,778,514 Rental, service and maintenance expense 552,195 — — 552,195 Equipment 317,406 — — 317,406 Selling, general and administrative 4,713,923 1,026,235 — 5,740,158 Impairment expense — 917,420 — 917,420 Depreciation and amortization 374,105 1,373,004 — 1,747,109 Total operating expenses 5,957,629 6,095,173 — 12,052,802 Loss from operations (3,965,135) (4,711,517) — (8,676,652) Other (income) expenses, net 1,063,714 1,979,331 — 3,043,045 Net loss $ (5,028,849) $ (6,690,848) $ — $ (11,719,697) Condensed Consolidating Statement of Cash Flows for the nine months ended September 30, 2020 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Cash flows used in operating activities: Net loss $ (5,028,849) $ (6,690,848) $ — $ (11,719,697) Non-cash adjustments to reconcile net loss to net cash used in operations 2,693,646 2,424,869 — 5,118,515 Changes in operating assets and liabilities (5,625,051) 4,715,544 — (909,507) Net cash used in operations (7,960,254) 449,565 — (7,510,689) Cash flow used in investing activities: Purchases of construction in-progress, equipment, fixtures and vehicles (3,538) (203,635) — (207,173) Other investing activities (57,949) — — (57,949) Net cash used in investing activities (61,487) (203,635) — (265,122) Cash flows from financing activities: Issuances of debt and equity 11,144,230 — — 11,144,230 Repayments of debt (3,544) — — (3,544) Net cash provided by financing activities 11,140,686 — — 11,140,686 Effect of exchange rate on cash (18,129) — — (18,129) Cash – beginning of period (restricted and unrestricted) 1,847,526 3,689,426 — 5,536,952 Cash – end of period (restricted and unrestricted) $ 4,948,342 $ 3,935,356 $ — $ 8,883,698 Condensed Consolidating Balance Sheet as of December 31, 2019 Parent Entsorga West and other Virginia Subsidiaries LLC Eliminations Consolidated Assets Cash $ 1,847,526 $ — $ — $ 1,847,526 Restricted cash — 1,133,581 — 1,133,581 Other current assets 1,697,910 1,116,821 (64,669) 2,750,062 Current assets 3,545,436 2,250,402 (64,669) 5,731,169 Restricted cash — 2,555,845 — 2,555,845 HEBioT facility and other fixed assets 1,753,730 37,392,601 — 39,146,331 Operating lease right of use assets 48,021 897,026 — 945,047 MBT facility development and license costs 6,254,429 1,795,500 — 8,049,929 Investment in subsidiaries 10,864,783 — (10,864,783) — Goodwill — 58,000 — 58,000 Other assets 53,726 — — 53,726 Total assets $ 22,520,125 $ 44,949,374 $ (10,929,452) $ 56,540,047 Liabilities and stockholders’ equity Line of credit $ 1,479,848 $ — $ — $ 1,479,848 Current portion of WV EDA Bonds — 1,390,000 — 1,390,000 Other current liabilities 2,387,916 6,475,985 (650,894) 8,213,007 Current liabilities 3,867,764 7,865,985 (650,894) 11,082,855 Notes payable and other debts 5,118,125 — — 5,118,125 Accrued interest 1,510,193 — — 1,510,193 Non-current lease liabilities - 915,170 — 915,170 WV EDA bonds — 29,817,426 — 29,817,426 Total liabilities 10,496,082 38,598,581 (650,894) 48,443,769 Redeemable preferred stock 726,553 — — 726,553 Stockholders' equity: Attributable to parent 2,024,143 — — 2,024,143 Attributable to non-controlling interests 9,273,347 6,350,793 (10,278,558) 5,345,582 Stockholders’ equity 11,297,490 6,350,793 (10,278,558) 7,369,725 Total liabilities and stockholders’ equity $ 22,520,125 $ 44,949,374 $ (10,929,452) $ 56,540,047 Condensed Consolidating Statement of Operations for the three months ended September 30, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Revenue $ 816,870 $ 609,905 $ — $ 1,426,775 Operating expenses HEBioT — 786,680 — 786,680 Rental, service and maintenance expense 176,651 — — 176,651 Equipment sales 17,776 — — 17,776 Selling, general and administrative 1,203,519 246,026 — 1,449,545 Depreciation and amortization 120,899 490,469 — 611,368 Total operating expenses 1,518,845 1,523,175 — 3,042,020 Loss from operations (701,975) (913,270) — (1,615,245) Other (income) expenses, net (180,837) 600,402 — 419,565 Net loss $ (521,138) $ (1,513,672) $ — $ (2,034,810) Condensed Consolidating Statement of Operations for the nine months ended September 30, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Revenue $ 2,325,742 $ 886,947 $ — $ 3,212,689 Operating expenses HEBioT — 1,309,176 — 1,309,176 Rental, service and maintenance expense 508,164 — — 508,164 Equipment sales 56,502 — — 56,502 Selling, general and administrative 4,678,415 771,867 — 5,450,282 Depreciation and amortization 369,843 980,937 — 1,350,780 Total operating expenses 5,612,924 3,061,980 — 8,674,904 Loss from operations (3,287,182) (2,175,033) — (5,462,215) Other expenses 273,851 1,361,221 86,362 1,721,434 Net loss $ (3,561,033) $ (3,536,254) $ (86,362) $ (7,183,649) Condensed Consolidating Statement of Cash Flows for the nine months ended September 30, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Cash flows used in operating activities: Net loss $ (3,561,033) $ (3,536,254) $ (86,362) $ (7,183,649) Non-cash adjustments to reconcile net loss to net cash used in operations 1,153,022 1,064,563 86,362 2,303,947 Changes in operating assets and liabilities (697,598) (440,212) — (1,137,810) Net cash used in operations (3,105,609) (2,911,903) — (6,017,512) Cash flow used in investing activities: Construction of HEBioT facility and acquisitions of equipment 98 (4,619,981) — (4,619,883) Capital contribution to Entsorga West Virginia, LLC (4,586,362) — 4,586,362 - Other investing activities 2,256,987 — — 2,256,987 Net cash used in investing activities (2,329,277) (4,619,981) 4,586,362 (2,362,896) Cash flows from financing activities: Issuances of debt and equity 6,418,057 4,586,362 (4,586,362) 6,418,057 Repayments of debt (6,846) — — (6,846) Deferred financing costs incurred - (62,151) — (62,151) Net cash provided by financing activities 6,411,211 4,524,211 (4,586,362) 6,349,060 Effect of exchange rate on cash 12,721 — — 12,721 Cash – beginning of period (restricted and unrestricted) 2,410,708 6,715,672 — 9,126,380 Cash – end of period (restricted and unrestricted) $ 3,399,754 $ 3,707,999 $ — $ 7,107,753

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2020
Summary of Significant Accounting Policies
Recent Accounting Pronouncements:	Recent Accounting Pronouncements: The Company has not implemented any recent accounting pronouncements during the nine months ended September 30, 2020. The Company has not implemented the following accounting standard: In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments . This standard requires an allowance to be recorded for all expected credit losses for certain financial assets. The new standard introduces an approach, based on expected losses, to estimate credit losses on certain types of financial instruments. ASU 2016-13 is effective for public companies for interim and annual period beginning December 15, 2020. Entities are required to apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. The Company has not yet adopted this update and is currently evaluating the effect this new standard will have on its financial condition and results of operations. In March 2020, the FASB issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The amendments in this update provide optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting as the market transitions from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. The amendments in this update were effective upon issuance for all entities through December 31, 2022. The Company is currently evaluating the effect the updated standard will have on its financial position, results of operations or financial statement disclosure. In August 2020, the FASB issued ASU No. 2020-06, Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40). The new guidance eliminates the beneficial conversion and cash conversion accounting models for convertible instruments. It also amends the accounting for certain contracts in an entity’s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation. This guidance is effective as of January 1, 2022 (Early adoption is permitted effective January 1, 2021). The Company is currently evaluating the effect the updated standard will have on its financial position, results of operations or financial statement disclosure. There have been no other recent accounting pronouncements or changes in accounting pronouncements that have been issued but not yet adopted that are of significance, or potential significance, to the Company.

Equipment on Operating Leases_2

Equipment on Operating Leases, net (Tables)	9 Months Ended
	Sep. 30, 2020
Equipment on Operating Leases, net.
Schedule of equipment on operating leases	Equipment on operating leases consist of the following: September 30, December 31, 2020 2019 Leased equipment $ 3,126,761 $ 3,138,951 Less: accumulated depreciation (1,709,501) (1,413,953) Total Equipment on Operating Leases, net $ 1,417,260 $ 1,724,998
Schedule Of future minimum rental payments receivable for operating leases	The minimum future estimated contractual payments to be received under these leases as of September 30, 2020 is as follows: Year ending December 31, 2020, remaining period $ 328,885 2021 971,888 2022 705,948 2023 534,345 2024 and thereafter 164,572 $ 2,705,638

HEBioT facility, equipment, f_2

HEBioT facility, equipment, fixtures and vehicles, net (Tables)	9 Months Ended
	Sep. 30, 2020
HEBioT facility, equipment, fixtures and vehicles, net
Schedule of HEBioT facility, equipment, fixtures and vehicles	HEBioT facility, equipment, fixtures and vehicles, net consist of the following: September 30, December 31, 2020 2019 HEBioT facility $ 31,172,855 $ 31,142,974 HEBioT equipment 7,562,649 7,388,896 Computer software and hardware 115,194 112,629 Furniture and fixtures 48,196 48,196 Vehicles 50,319 50,319 38,949,213 38,743,014 Less: accumulated depreciation and amortization (2,610,486) (1,321,681) Total HEBioT facility, equipment, fixtures and vehicles, net $ 36,338,727 $ 37,421,333

MBT Facility Development and _2

MBT Facility Development and License Costs (Tables)	9 Months Ended
	Sep. 30, 2020
MBT Facility Development and License Costs
Schedule of MBT facility development and license costs	MBT Facility Development and License Costs consist of the following: September 30, December 31, 2020 2019 MBT Projects Survey and engineering $ 298,653 $ 235,229 Technology Licenses Future site 6,019,200 6,019,200 Martinsburg, West Virginia, net of $189,000 and $94,500 of amortization as of September 30, 2020 and December 31, 2019 1,701,000 1,795,500 Total Technology Licenses 7,720,200 7,814,700 Total MBT Facility Development and License Costs $ 8,018,853 $ 8,049,929

Line of Credit, Promissory No_2

Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts (Tables)	9 Months Ended
	Sep. 30, 2020
Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts
Schedule of long-term debt	Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts consist of the following: September 30, 2020 December 31, 2019 Related Related Total Party Total Party Line of credit $ 1,497,950 $ — $ 1,479,848 $ — Senior secured promissory note 4,408,514 — 4,160,490 — Junior promissory note 965,881 965,881 949,434 949,434 Note payable under Payroll Protection Program 421,300 — — — Note payable 100,000 — 100,000 — Advances from related parties (See Note 14 Related Parties) 935,000 935,000 210,000 210,000 Long term debt - current and long-term portion 9,262 — 12,806 —
Schedule of maturities of long-term debts	and matures on January 1, 2022. Contractual Maturities of Senior Secured, Junior Promissory, Notes Payable and Long Term Debt — As of September 30, 2020, excluding discounts and deferred finance costs, which are being amortized as interest expense, are as follow: Non- Year Ending December 31, Amortizing Amortizing Total 2020 (Remaining) $ 1,061 $ 23,406 $ 24,467 2021 4,380 2,155,866 2,160,246 2022 3,821 2,717,028 2,720,849 2023 — 625,000 625,000 2024 and thereafter — 1,044,477 1,044,477 Total $ 9,262 $ 6,565,777 $ 6,575,039

Entsorga West Virginia, LLC W_2

Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds (Tables)	9 Months Ended
	Sep. 30, 2020
Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds
Schedule of future sinking fund payments by the borrower	The future sinking fund payments by the Borrower as of September 30, 2020 are as follow: 2016 Issue 2016 Issue 2018 Issue Year Ending December 31, 2026 Series 2036 Series 2036 Series Total 2020 (remaining) $ 1,160,000 $ — $ 230,000 $ 1,390,000 2021 1,215,000 — 255,000 1,470,000 2022 900,000 — 275,000 1,175,000 2023 965,000 — 300,000 1,265,000 2024 and thereafter 3,295,000 17,465,000 6,940,000 27,700,000 Total $ 7,535,000 $ 17,465,000 $ 8,000,000 $ 33,000,000

Equity and Equity Transactions

Equity and Equity Transactions (Tables)	9 Months Ended
	Sep. 30, 2020
Equity and Equity Transactions
Schedule of preferred units	As of September 30, 2020 and December 31, 2019, 23,354,130 and 17,300,899 shares of common stock have been issued; and 3,209,210 and 3,179,120 shares, respectively, of preferred stock have been designated in five series of shares, which have a total of $1,602,675 in accumulated, but undeclared preferential dividends as of September 30, 2020, as follows: Designated Par Stated Shares Outstanding Designation Shares Value Value September 30, 2020 December 31, 2019 Series A Convertible Preferred Stock 333,401 $ 0.0001 $ 5.00 125,312 145,312 Series B Convertible Preferred Stock 1,111,200 0.0001 $ 5.00 — — Series C Convertible Preferred Stock 1,000,000 0.0001 $ 10.00 427,500 427,500 Series D Convertible Preferred Stock 20,000 0.0001 $ 100.00 17,350 18,850 Series E Convertible Preferred Stock 714,519 0.0001 $ 2.64 264,519 264,519 Series F Convertible Preferred Stock 30,090 0.0001 $ 115.00 13,611 —
Schedule of share-based compensation, activity	the Company has warrants to acquire 4,676,361 shares of the Company’s common stock outstanding as of September 30, 2020, as follows: Weighted Average Expiring During the Year Warrant Exercise Price Exercises Price Ending December 31, Shares per Share per Share 2021 1,701,827 $3.30 - $3.75 $ 2022 1,253,149 $1.80 - $5.00 $ 2023 740,749 $1.80 $ 2024 269,293 $1.80 $ 2025 711,343 $1.80 - $2.25 $
Schedule of warrants or rights outstanding	The following table summarizes the outstanding warrant activity for the nine months ended September 30, 2020: Outstanding, January 1, 2020 4,674,261 Issued as a result of Series F Convertible Preferred Stock offering 186,347 Issued to common stock offering underwriters 318,666 Issued to professional services providers 150,000 Exercised (630,053) Expired (22,860) Outstanding, September 30, 2020 4,676,361
Summary of net proceeds from the offering	The net proceeds to the Company from the offering were: Gross proceeds at $1.81 per share $ 9,470,825 Less: Underwriters’ fees (852,374) Legal fees (139,033) Accounting fees (30,900) Filing and other fees (11,038) Net proceeds to the Company $ 8,437,480

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	9 Months Ended
	Sep. 30, 2020
Equity Incentive Plans
Schedule of compensation expenses related to stock options and restricted stock	Compensation expense related to stock options and restricted stock was: Three months ended September 30, Nine months ended September 30, 2020 2019 2020 2019 Stock options $ 34,605 $ 31,323 $ 124,383 $ 104,075 Restricted stock 438,042 178,262 940,886 637,113 Total $ 472,647 $ 209,585 $ 1,065,269 $ 741,188 Compensation expense related to stock options and restricted stock for are reflected in the following captions within operating expenses in the condensed consolidated statements of operations and comprehensive loss: Three months ended September 30, Nine months ended September 30, 2020 2019 2020 2019 Rental, service and maintenance $ 2,097 $ 3,353 $ 8,416 $ 12,426 Selling, general and administrative 470,550 206,232 1,056,853 728,762 Total $ 472,647 $ 209,585 $ 1,065,269 $ 741,188
Schedule of restricted stock	The following summarizes the Company’s stock option activity for the nine months ended September 30, 2020: Weighted Average Weighted Remaining Average Contractual Number of Exercise Life Aggregate Options Price (in Years) Intrinsic Value Outstanding – January 1, 2020 363,826 $ 3.71 — Granted 155,450 — — Exercised — — — — Forfeited, Canceled or Expired (58,417) — — Outstanding – September 30, 2020 460,859 3.16 — Exercisable – September 30, 2020 307,021 3.49 — The following summarizes the Company’s restricted stock unit activity for the nine months ended September 30, 2020: Balance, January 1, 2020 291,730 Grants 405,205 Forfeited — Vested (403,233) Balance, September 30, 2020 293,702

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Sep. 30, 2020
Revenue
Schedule of disaggregation of revenue	Disaggregation of Revenue — The disaggregation of revenue is as follows: Three months ended September 30, Nine months ended September 30, 2020 2019 2020 2019 Revenue Type: Rental of digesters $ 356,001 $ 369,438 $ 1,054,534 $ 1,061,289 Services 250,177 960,146 1,428,017 1,929,174 Product sales 136,699 97,191 893,599 222,226 Total $ 742,877 $ 1,426,775 $ 3,376,150 $ 3,212,689

Risk Concentrations (Tables)

Risk Concentrations (Tables)	9 Months Ended
	Sep. 30, 2020
Risk Concentrations
Schedule of revenue from external customers by geographic areas	The Company operates as a single segment on a worldwide basis through its subsidiaries, resellers and independent sales agents. Gross revenues and net non-current tangible assets on a domestic and international basis are as follows: United States International Total 2020: Revenue, for the nine months ended September 30, 2020 $ 3,079,083 $ 297,067 $ 3,376,150 Revenue, for the three months ended September 30, 2020 631,450 111,427 742,877 Non-current tangible assets, as of September 30, 2020 37,469,194 295,293 37,764,487 2019: Revenue, for the nine months ended September 30, 2019 $ 2,877,157 $ 335,532 $ 3,212,689 Revenue, for the three months ended September 30, 2019 1,333,878 92,897 1,426,775 Non-current tangible assets, as of December 31, 2019 38,803,833 355,825 39,159,658

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2020
Leases
Schedule of maturities of lease liabilities	Maturities of lease liabilities under these leases, which have a weighted average remaining term of 19.7 years, as of September 30, 2020 is: Year Ending December 31, 2020 (remaining) $ 51,783 2021 212,026 2022 217,571 2023 219,140 2024 and thereafter 3,133,649 Total lease payments 3,834,169 Less imputed interest (2,419,658) Present value of lease liabilities $ 1,414,511

Related Party Transactions (Tab

Related Party Transactions (Tables)	9 Months Ended
	Sep. 30, 2020
Related Party Transactions
Schedule of related party transactions	The table below presents the face amount of direct related party assets and liabilities and other transactions or conditions as of or during the periods indicated. September 30, December 31, 2020 2019 Assets: Accounts receivable (a) (b) $ 2,227,224 $ 1,370,867 Intangible assets, net, included in other assets (c) 25,249 40,399 Liabilities: Accounts payable (c) (d) (e) (f) 3,851,722 2,531,034 Accrued interest payable 165,396 46,796 Long term accrued interest (g) 1,729,605 1,510,193 Advance from related party (h) 935,000 210,000 Junior promissory note (g) 965,881 949,434 Other: Line of credit guarantee (i) 1,497,950 1,479,848 The table below presents direct related party expenses or transactions for the three and nine months ended September 30, 2020 and 2019. Compensation and related costs for employees of the Company are excluded from the table below. Three months ended September 30, Nine months ended September 30, 2020 2019 2020 2019 Management advisory and other fees (a) $ 25,000 $ 250,000 $ 125,000 $ 750,000 HEBioT revenue (b) 115,173 590,262 970,943 831,274 Operating expenses - HEBioT (d) 178,545 210,709 952,931 354,733 Operating expenses - Selling, general and administrative (e) — 24,537 41,514 73,611 Operating expenses - Selling, general and administrative (c) (f) 110,650 110,650 332,016 258,050 Interest expense 98,571 76,611 295,592 194,266 Debt guarantee fees (i) 16,875 16,875 50,625 50,625 Summary notes: a - Management Advisory Fees f - Business Services Fees b - HEBioT Disposal Revenues g - Junior Promissory Note c - Distribution Agreement h - Advances from Related Parties d - Disposal costs i - Line of Credit e - Facility Lease

Supplemental Consolidated Sta_2

Supplemental Consolidated Statement of Cash Flows Information (Tables)	9 Months Ended
	Sep. 30, 2020
Supplemental Consolidated Statement of Cash Flows Information
Schedule of supplemental cash flow	Changes in non-cash operating assets and liabilities, as well as other supplemental cash flow disclosures, are as follows. Nine Months Ended September 30, 2020 2019 Changes in operating assets and liabilities: Accounts receivable $ (1,302,729) $ (1,335,024) Inventory (210,886) (181,979) Prepaid expenses and other assets (94,156) (3,300) Accounts payable 1,149,030 3,111,285 Accrued interest payable (322,753) (260,046) Accrued expenses (843,188) (2,504,724) Deferred revenue 6,921 (1,131) Customer deposits 708,254 37,109 Net change in operating assets and liabilities $ (909,507) $ (1,137,810) Supplementary cash flow information: Cash paid during the periods for: Interest $ 1,596,332 $ 2,625,018 Income taxes — — Supplementary Disclosure of Non-Cash Investing and Financing Activities: Transfer of inventory to leased equipment $ 84,501 $ 259,449 Accrual of Series A preferred stock dividends 52,654 140,631 Conversion of preferred stock into common 239,566 90,000 Payment of preferred stock dividends in common stock 21,732 50,000 Acquisition of right of use leased asset and creation of lease liability 412,647 — Reconciliation of Cash and Restricted Cash: Cash $ 4,950,112 $ 3,434,089 Restricted cash (current) 1,287,138 1,128,716 Restricted cash (non-current) 2,646,448 2,544,948 Total cash and restricted cash at the end of the period $ 8,883,698 $ 7,107,753

Condensed Consolidating Finan_2

Condensed Consolidating Financial Information (Tables)	9 Months Ended
	Sep. 30, 2020
Condensed Consolidating Financial Information
Schedule of condensed financial statements	Condensed Consolidating Balance Sheet as of September 30, 2020 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Assets Cash $ 4,948,342 $ 1,770 $ — $ 4,950,112 Restricted cash — 1,287,138 — 1,287,138 Other current assets 2,085,508 2,094,211 — 4,179,719 Current assets 7,033,850 3,383,119 — 10,416,969 Restricted cash — 2,646,448 — 2,646,448 HEBioT facility and other fixed assets 1,438,255 36,317,732 — 37,755,987 Operating lease right of use assets 396,562 888,730 — 1,285,292 MBT facility development and license costs 6,317,853 1,701,000 — 8,018,853 Investment in subsidiaries and intercompany accounts 16,444,214 — (16,444,214) — Goodwill — 58,000 — 58,000 Other assets 33,749 — — 33,749 Total assets $ 31,664,483 $ 44,995,029 $ (16,442,214) $ 60,215,298 Liabilities and stockholders’ equity Line of credit $ 1,497,950 $ — $ — $ 1,497,950 Current portion of Debts and Bonds 4,670,301 2,860,000 — 7,530,301 Other current liabilities 3,716,174 13,081,770 (5,948,711) 10,849,233 Current liabilities 9,884,425 15,941,770 (5,948,711) 19,877,484 Notes payable and other debts 1,234,656 — — 1,234,656 Accrued interest 1,729,605 — — 1,729,605 Non-current lease liabilities 286,314 944,830 — 1,231,144 WV EDA bonds — 28,448,484 — 28,448,484 Total liabilities 13,135,000 45,335,084 (5,948,711) 52,521,373 Redeemable preferred stock 626,553 — — 626,553 Stockholders' equity: Attributable to parent 15,748,136 (340,055) (10,495,503) 4,912,578 Attributable to non-controlling interests 2,154,794 — — 2,154,794 Stockholders’ equity 17,902,930 (340,055) (10,495,503) 7,067,372 Total liabilities and stockholders’ equity $ 31,664,483 $ 44,995,029 $ (16,444,214) $ 60,215,298 Condensed Consolidating Balance Sheet as of December 31, 2019 Parent Entsorga West and other Virginia Subsidiaries LLC Eliminations Consolidated Assets Cash $ 1,847,526 $ — $ — $ 1,847,526 Restricted cash — 1,133,581 — 1,133,581 Other current assets 1,697,910 1,116,821 (64,669) 2,750,062 Current assets 3,545,436 2,250,402 (64,669) 5,731,169 Restricted cash — 2,555,845 — 2,555,845 HEBioT facility and other fixed assets 1,753,730 37,392,601 — 39,146,331 Operating lease right of use assets 48,021 897,026 — 945,047 MBT facility development and license costs 6,254,429 1,795,500 — 8,049,929 Investment in subsidiaries 10,864,783 — (10,864,783) — Goodwill — 58,000 — 58,000 Other assets 53,726 — — 53,726 Total assets $ 22,520,125 $ 44,949,374 $ (10,929,452) $ 56,540,047 Liabilities and stockholders’ equity Line of credit $ 1,479,848 $ — $ — $ 1,479,848 Current portion of WV EDA Bonds — 1,390,000 — 1,390,000 Other current liabilities 2,387,916 6,475,985 (650,894) 8,213,007 Current liabilities 3,867,764 7,865,985 (650,894) 11,082,855 Notes payable and other debts 5,118,125 — — 5,118,125 Accrued interest 1,510,193 — — 1,510,193 Non-current lease liabilities - 915,170 — 915,170 WV EDA bonds — 29,817,426 — 29,817,426 Total liabilities 10,496,082 38,598,581 (650,894) 48,443,769 Redeemable preferred stock 726,553 — — 726,553 Stockholders' equity: Attributable to parent 2,024,143 — — 2,024,143 Attributable to non-controlling interests 9,273,347 6,350,793 (10,278,558) 5,345,582 Stockholders’ equity 11,297,490 6,350,793 (10,278,558) 7,369,725 Total liabilities and stockholders’ equity $ 22,520,125 $ 44,949,374 $ (10,929,452) $ 56,540,047
Schedule of condensed income statement	Condensed Consolidating Statement of Operations for the three months ended September 30, 2020 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Revenue $ 742,252 $ 625 $ — $ 742,877 Operating expenses HEBioT — 945,810 — 945,810 Rental, service and maintenance expense 139,665 — — 139,665 Equipment 171,002 — — 171,002 Selling, general and administrative 1,430,095 494,198 — 1,924,293 Impairment expense — 917,420 — 917,420 Depreciation and amortization 124,759 437,384 — 562,143 Total operating expenses 1,865,521 2,794,812 — 4,660,333 Loss from operations (1,123,269) (2,794,187) — (3,917,456) Other (income) expenses, net 336,749 686,308 — 1,023,057 Net loss $ (1,460,018) $ (3,480,495) $ — $ (4,940,513) Condensed Consolidating Statement of Operations for the nine months ended September 30, 2020 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Revenue $ 1,992,494 $ 1,383,656 $ — $ 3,376,150 Operating expenses HEBioT — 2,778,514 — 2,778,514 Rental, service and maintenance expense 552,195 — — 552,195 Equipment 317,406 — — 317,406 Selling, general and administrative 4,713,923 1,026,235 — 5,740,158 Impairment expense — 917,420 — 917,420 Depreciation and amortization 374,105 1,373,004 — 1,747,109 Total operating expenses 5,957,629 6,095,173 — 12,052,802 Loss from operations (3,965,135) (4,711,517) — (8,676,652) Other (income) expenses, net 1,063,714 1,979,331 — 3,043,045 Net loss $ (5,028,849) $ (6,690,848) $ — $ (11,719,697) Condensed Consolidating Statement of Operations for the three months ended September 30, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Revenue $ 816,870 $ 609,905 $ — $ 1,426,775 Operating expenses HEBioT — 786,680 — 786,680 Rental, service and maintenance expense 176,651 — — 176,651 Equipment sales 17,776 — — 17,776 Selling, general and administrative 1,203,519 246,026 — 1,449,545 Depreciation and amortization 120,899 490,469 — 611,368 Total operating expenses 1,518,845 1,523,175 — 3,042,020 Loss from operations (701,975) (913,270) — (1,615,245) Other (income) expenses, net (180,837) 600,402 — 419,565 Net loss $ (521,138) $ (1,513,672) $ — $ (2,034,810) Condensed Consolidating Statement of Operations for the nine months ended September 30, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Revenue $ 2,325,742 $ 886,947 $ — $ 3,212,689 Operating expenses HEBioT — 1,309,176 — 1,309,176 Rental, service and maintenance expense 508,164 — — 508,164 Equipment sales 56,502 — — 56,502 Selling, general and administrative 4,678,415 771,867 — 5,450,282 Depreciation and amortization 369,843 980,937 — 1,350,780 Total operating expenses 5,612,924 3,061,980 — 8,674,904 Loss from operations (3,287,182) (2,175,033) — (5,462,215) Other expenses 273,851 1,361,221 86,362 1,721,434 Net loss $ (3,561,033) $ (3,536,254) $ (86,362) $ (7,183,649)
Schedule of condensed cash flow Statement	Condensed Consolidating Statement of Cash Flows for the nine months ended September 30, 2020 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Cash flows used in operating activities: Net loss $ (5,028,849) $ (6,690,848) $ — $ (11,719,697) Non-cash adjustments to reconcile net loss to net cash used in operations 2,693,646 2,424,869 — 5,118,515 Changes in operating assets and liabilities (5,625,051) 4,715,544 — (909,507) Net cash used in operations (7,960,254) 449,565 — (7,510,689) Cash flow used in investing activities: Purchases of construction in-progress, equipment, fixtures and vehicles (3,538) (203,635) — (207,173) Other investing activities (57,949) — — (57,949) Net cash used in investing activities (61,487) (203,635) — (265,122) Cash flows from financing activities: Issuances of debt and equity 11,144,230 — — 11,144,230 Repayments of debt (3,544) — — (3,544) Net cash provided by financing activities 11,140,686 — — 11,140,686 Effect of exchange rate on cash (18,129) — — (18,129) Cash – beginning of period (restricted and unrestricted) 1,847,526 3,689,426 — 5,536,952 Cash – end of period (restricted and unrestricted) $ 4,948,342 $ 3,935,356 $ — $ 8,883,698 Condensed Consolidating Statement of Cash Flows for the nine months ended September 30, 2019 Parent Entsorga and other West Subsidiaries Virginia LLC Eliminations Consolidated Cash flows used in operating activities: Net loss $ (3,561,033) $ (3,536,254) $ (86,362) $ (7,183,649) Non-cash adjustments to reconcile net loss to net cash used in operations 1,153,022 1,064,563 86,362 2,303,947 Changes in operating assets and liabilities (697,598) (440,212) — (1,137,810) Net cash used in operations (3,105,609) (2,911,903) — (6,017,512) Cash flow used in investing activities: Construction of HEBioT facility and acquisitions of equipment 98 (4,619,981) — (4,619,883) Capital contribution to Entsorga West Virginia, LLC (4,586,362) — 4,586,362 - Other investing activities 2,256,987 — — 2,256,987 Net cash used in investing activities (2,329,277) (4,619,981) 4,586,362 (2,362,896) Cash flows from financing activities: Issuances of debt and equity 6,418,057 4,586,362 (4,586,362) 6,418,057 Repayments of debt (6,846) — — (6,846) Deferred financing costs incurred - (62,151) — (62,151) Net cash provided by financing activities 6,411,211 4,524,211 (4,586,362) 6,349,060 Effect of exchange rate on cash 12,721 — — 12,721 Cash – beginning of period (restricted and unrestricted) 2,410,708 6,715,672 — 9,126,380 Cash – end of period (restricted and unrestricted) $ 3,399,754 $ 3,707,999 $ — $ 7,107,753

Basis of Presentation and Goi_2

Basis of Presentation and Going Concern (Details) - USD ($)	Aug. 11, 2020	Jul. 27, 2020	May 13, 2020	Oct. 31, 2020	Aug. 11, 2020	Apr. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Oct. 31, 2020	Jun. 30, 2020	Apr. 06, 2020	Dec. 31, 2019	Jun. 30, 2019	Dec. 31, 2018
Basis Of Presentation And Going Concern [Line Items]
Unfulfilled equipment orders due to COVID-19											$ 2,100,000
Unfulfilled shipment orders due to COVID-19				$ 600,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest							$ 4,940,513	$ 2,034,810	$ 11,719,697	$ 7,183,649
Operating Income (Loss)							3,917,456	1,615,245	8,676,652	5,462,215
Net Cash Provided by (Used in) Operating Activities									(7,510,689)	(6,017,512)
Working Capital Deficit									9,460,515
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest							7,067,372		7,067,372					$ 7,369,725
Stockholders' Equity Attributable to Parent							4,912,578	$ 3,922,118	4,912,578	3,922,118		$ (1,038,936)		$ 2,024,143	$ 1,880,500	$ 3,405,551
Application amount approved and funded under paycheck protection program			$ 421,300
Proceeds from common stock issuance, net of offering costs		$ 8,235,500					8,437,480		8,437,480	$ 3,035,557
Proceeds from Issuance of Convertible Preferred Stock						$ 1,560,450
Senior Notes, Current							$ 4,408,514		$ 4,408,514
Common Stock, Par or Stated Value Per Share							$ 0.0001		$ 0.0001				$ 2.30	$ 0.0001
Underwriting agreement
Basis Of Presentation And Going Concern [Line Items]
Sale of Stock, Number of Shares Issued in Transaction	682,500	4,550,000
Stock Issued During Period, Shares, New Issues	682,500	4,550,000
Gross Purchase Price	$ 1,235,325
Common Stock, Par or Stated Value Per Share	$ 1.81	$ 1.81			$ 1.81
Amount After Underwriters Commission and Before Other Cost	$ 1,124,146				$ 8,437,480
Refuel America LLC [Member]
Basis Of Presentation And Going Concern [Line Items]
Equity Method Investment, Ownership Percentage							60.00%		60.00%
Entsorgia West Virginia LLC [Member]
Basis Of Presentation And Going Concern [Line Items]
Equity Method Investment, Ownership Percentage							88.70%		88.70%			88.70%		88.70%

Equipment on Operating Leases_3

Equipment on Operating Leases, net (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Less: accumulated depreciation	$ (2,610,486)	$ (1,321,681)
Total Equipment on Operating Leases, net	1,417,260	1,724,998
Assets Held under Operating Leases [Member]
Leased equipment	3,126,761	3,138,951
Less: accumulated depreciation	(1,709,501)	(1,413,953)
Total Equipment on Operating Leases, net	$ 1,417,260	$ 1,724,998

Equipment on Operating Leases_4

Equipment on Operating Leases, net - Minimum Future Estimated Contractual Payments to be Received (Details)	Sep. 30, 2020USD ($)
Equipment on Operating Leases, net.
2020, remaining period	$ 328,885
2021	971,888
2022	705,948
2023	534,345
2024 and thereafter	164,572
Total minimum lease income	$ 2,705,638

Equipment on Operating Leases_5

Equipment on Operating Leases, net - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Leases
Operating Leases, Income Statement, Lease Revenue, Total	$ 356,002	$ 369,437	$ 1,054,534	$ 1,061,289
Depreciation	$ 116,461	$ 110,795	$ 348,599	$ 316,061

HEBioT facility, equipment, f_3

HEBioT facility, equipment, fixtures and vehicles, net (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Plant and Equipment, Gross	$ 38,949,213	$ 38,743,014
Less: accumulated depreciation and amortization	(2,610,486)	(1,321,681)
Total HEBioT facility, equipment, fixtures and vehicles, net	36,338,727	37,421,333
HEBioT facility
Property, Plant and Equipment [Line Items]
Plant and Equipment, Gross	31,172,855	31,142,974
HEBiot equipment
Property, Plant and Equipment [Line Items]
Plant and Equipment, Gross	7,562,649	7,388,896
Computer Software And Hardware [Member]
Property, Plant and Equipment [Line Items]
Plant and Equipment, Gross	115,194	112,629
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Plant and Equipment, Gross	48,196	48,196
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Plant and Equipment, Gross	$ 50,319	$ 50,319

MBT Facility Development and _3

MBT Facility Development and License Costs (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Land and Land Improvements	$ 8,018,853	$ 8,049,929
Survey and Engineering Costs [Member]
Land and Land Improvements	298,653	235,229
Technology Licenses Cost [Member]
Land and Land Improvements	7,720,200	7,814,700
Technology Licenses Cost [Member] | Future Site [Member]
Land and Land Improvements	6,019,200	6,019,200
Technology Licenses Cost [Member] | Martinsburg West Virginia [Member]
Land and Land Improvements	$ 1,701,000	$ 1,795,500

MBT Facility Development and _4

MBT Facility Development and License Costs - Additional Information (Details) - USD ($)	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Dec. 31, 2018
Royalty Guarantees, Commitments, Amount	$ 6,019,200			$ 6,019,200
Asset Impairment Charges	917,420			917,420
Intellectual Property [Member]
Finite-lived Intangible Assets Acquired							$ 1,890,000
Amortization Expenses	$ 31,500	$ 31,500	$ 0	94,500	$ 63,000
Martinsburg West Virginia [Member] | Intellectual Property [Member]
Amortization Expenses				$ 189,000		$ 94,500

Line of Credit, Promissory No_3

Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Line of credit	$ 1,497,950	$ 1,479,848
Senior secured promissory note	4,408,514	4,160,490
Junior promissory note	965,881	949,434
Note payable under Payroll Protection Program	421,300	0
Notes payable	100,000	100,000
Advances from related parties	935,000	210,000
Long term debt - current and long-term portion	9,262	12,806
Related Party [Member]
Debt Instrument [Line Items]
Line of credit	0	0
Senior secured promissory note	0	0
Junior promissory note	965,881	949,434
Note payable under Payroll Protection Program	0	0
Notes payable	0	0
Advances from related parties	935,000	210,000
Long term debt - current and long-term portion	$ 0	$ 0

Line of Credit, Promissory No_4

Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts - Contractual maturities of Long Term Debts (Details)	Sep. 30, 2020USD ($)
2020 (Remaining)	$ 24,467
2021	2,160,246
2022	2,720,849
2023	625,000
2024 and thereafter	1,044,477
Total	6,575,039
Amortizing [Member]
2020 (Remaining)	1,061
2021	4,380
2022	3,821
2023	0
2024 and thereafter	0
Total	9,262
Non-Amortizing [Member]
2020 (Remaining)	23,406
2021	2,155,866
2022	2,717,028
2023	625,000
2024 and thereafter	1,044,477
Total	$ 6,565,777

Line of Credit, Promissory No_5

Line of Credit, Promissory Notes Payable, Notes Payable, Advances, and Long-Term Debts - Additional Information (Details) - USD ($)	Jun. 30, 2020	Sep. 30, 2020	May 13, 2020	Apr. 06, 2020	Dec. 31, 2019
Interest rate of stated percentage			1.00%
Effective interest rate		5.00%
Senior secured promissory note		$ 4,408,514			$ 4,160,490
Variable Interest rate on the debt instrument	1.00%
Payroll Protection Program Loan		163,839	$ 421,300
Line of credit carrying value as of the balance sheet		$ 1,497,950			$ 1,479,848
Preferred Stock, par value (in dollars per share)		$ 0.0001			$ 0.0001
Common stock, par value		$ 0.0001		$ 2.30	$ 0.0001
Junior promissory note		$ 965,881			$ 949,434
Current portion of Debts and Bonds		$ 2,860,000			$ 1,390,000
LIBOR [Member]
Variable Interest rate on the debt instrument	3.00%
Line of Credit [Member]
Effective interest rate		5.00%
Comerica Line of Credit [Member]
Effective interest rate	5.00%				5.71%
Variable Interest rate on the debt instrument		3.00%
Miichaelson Senior Secured Term Promissory [Member]
Debt Instruments of face values issue		$ 5,000,000
Interest rate of stated percentage		10.25%
Maturity date of debt instruments		Feb. 2, 2023
Principal installments payment		$ 625,000
Unsecured Debt [Member]
Debt Instruments of face values issue		$ 100,000			$ 100,000
Interest rate of stated percentage		10.00%			10.00%

Entsorga West Virginia, LLC W_3

Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds (Details)	9 Months Ended
	Sep. 30, 2020USD ($)
Debt Instrument, Sinking Fund Payment	$ 33,000,000
2020 (remaining)
Debt Instrument, Sinking Fund Payment	1,390,000
2021
Debt Instrument, Sinking Fund Payment	1,470,000
2022
Debt Instrument, Sinking Fund Payment	1,175,000
2023
Debt Instrument, Sinking Fund Payment	1,265,000
2024 and thereafter
Debt Instrument, Sinking Fund Payment	27,700,000
2016 Issue 2026 Series [Member]
Debt Instrument, Sinking Fund Payment	7,535,000
2016 Issue 2026 Series [Member] | 2020 (remaining)
Debt Instrument, Sinking Fund Payment	1,160,000
2016 Issue 2026 Series [Member] | 2021
Debt Instrument, Sinking Fund Payment	1,215,000
2016 Issue 2026 Series [Member] | 2022
Debt Instrument, Sinking Fund Payment	900,000
2016 Issue 2026 Series [Member] | 2023
Debt Instrument, Sinking Fund Payment	965,000
2016 Issue 2026 Series [Member] | 2024 and thereafter
Debt Instrument, Sinking Fund Payment	3,295,000
2016 Issue 2036 Series [Member]
Debt Instrument, Sinking Fund Payment	17,465,000
2016 Issue 2036 Series [Member] | 2024 and thereafter
Debt Instrument, Sinking Fund Payment	17,465,000
2018 Issue 2036 Series [Member]
Debt Instrument, Sinking Fund Payment	8,000,000
2018 Issue 2036 Series [Member] | 2020 (remaining)
Debt Instrument, Sinking Fund Payment	230,000
2018 Issue 2036 Series [Member] | 2021
Debt Instrument, Sinking Fund Payment	255,000
2018 Issue 2036 Series [Member] | 2022
Debt Instrument, Sinking Fund Payment	275,000
2018 Issue 2036 Series [Member] | 2023
Debt Instrument, Sinking Fund Payment	300,000
2018 Issue 2036 Series [Member] | 2024 and thereafter
Debt Instrument, Sinking Fund Payment	$ 6,940,000

Entsorga West Virginia, LLC W_4

Entsorga West Virginia, LLC WVEDA Solid Waste Disposal Revenue Bonds - Additional Information (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2016	May 13, 2020
Interest rate of stated percentage					1.00%
WVEDA Bonds [Member]
Debt Instruments of face values issue	$ 33,000,000	$ 33,000,000		$ 25,000,000
Unamortized Debt Issuance Expense	2,207,759	2,207,759
Amortization of Debt Issuance Costs	$ 516,243	$ 415,185
Series One [Member] | WVEDA Bonds [Member]
Debt Instruments of face values issue				$ 7,535,000
Interest rate of stated percentage				6.75%
Maturity date of debt instruments				Feb. 1, 2026
Series Two [Member] | WVEDA Bonds [Member]
Debt Instruments of face values issue				$ 17,465,000
Interest rate of stated percentage				7.25%
Maturity date of debt instruments				Feb. 1, 2036
Series Three [Member] | WVEDA Bonds [Member]
Debt Instruments of face values issue			$ 8,000,000
Interest rate of stated percentage			8.75%
Maturity date of debt instruments			Feb. 1, 2036

Equity and Equity Transaction_2

Equity and Equity Transactions (Details) - $ / shares	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Preferred Stock, Authorized Shares	3,209,210	3,179,120
Preferred Stock, Shares Outstanding	848,292	856,181
Series A Convertible Preferred Stock [Member]
Preferred Stock, Authorized Shares	333,401
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 5
Preferred Stock, Shares Outstanding	125,312	145,312
Series B Convertible Preferred Stock [Member]
Preferred Stock, Authorized Shares	1,111,200
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 5
Preferred Stock, Shares Outstanding	0	0
Series C Convertible Preferred Stock [Member]
Preferred Stock, Authorized Shares	1,000,000	1,000,000
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 10
Preferred Stock, Shares Outstanding	427,500	427,500
Series D Convertible Preferred Stock
Preferred Stock, Authorized Shares	20,000	20,000
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 100
Preferred Stock, Shares Outstanding	17,350	18,850
Series E Convertible Preferred Stock [Member]
Preferred Stock, Authorized Shares	714,519	714,519
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 2.64
Preferred Stock, Shares Outstanding	264,519	264,519
Series F Convertible Preferred Stock [Member]
Preferred Stock, Authorized Shares	30,090
Preferred Stock, Par Value	$ 0.0001
Preferred Stock, Stated Value	$ 115
Preferred Stock, Shares Outstanding	13,611	0

Equity and Equity Transaction_3

Equity and Equity Transactions - Net Proceeds (Details) - USD ($)	Jul. 27, 2020	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2019
Equity and Equity Transactions
Gross proceeds at $1.81 per share			$ 9,470,825
Underwriters' fees			(852,374)
Legal fees			(139,033)
Accounting fees			(30,900)
Filing and other fees			(11,038)
Net proceeds to the Company	$ 8,235,500	$ 8,437,480	$ 8,437,480	$ 3,035,557

Equity and Equity Transaction_4

Equity and Equity Transactions - Warrants (Details) - $ / shares	Sep. 30, 2020	Jul. 27, 2020	Jul. 26, 2020	Jul. 13, 2020	Jun. 30, 2020	Dec. 31, 2019
Class of Warrant or Right, Outstanding	4,676,361					4,674,261
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 1.81	$ 2.30	$ 1.80	$ 1.80
Weighted Average Price per Share		$ 1.81
2021
Class of Warrant or Right, Outstanding	1,701,827
Weighted Average Price per Share	$ 3.30
2022
Class of Warrant or Right, Outstanding	1,253,149
Weighted Average Price per Share	$ 2.89
2023
Class of Warrant or Right, Outstanding	740,749
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.80
Weighted Average Price per Share	$ 1.80
2024
Class of Warrant or Right, Outstanding	269,293
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.80
Weighted Average Price per Share	$ 1.80
2025
Class of Warrant or Right, Outstanding	711,343
Weighted Average Price per Share	$ 1.92
Maximum [Member] | 2021
Class of Warrant or Right, Exercise Price of Warrants or Rights	3.75
Maximum [Member] | 2022
Class of Warrant or Right, Exercise Price of Warrants or Rights	5
Maximum [Member] | 2025
Class of Warrant or Right, Exercise Price of Warrants or Rights	2.25
Minimum [Member] | 2021
Class of Warrant or Right, Exercise Price of Warrants or Rights	3.30
Minimum [Member] | 2022
Class of Warrant or Right, Exercise Price of Warrants or Rights	1.80
Minimum [Member] | 2025
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.80

Equity and Equity Transaction_5

Equity and Equity Transactions - Outstanding Warrant Activity (Details)	9 Months Ended
	Sep. 30, 2020shares
Outstanding Beginning Balance	4,674,261
Issued to common stock offering underwriters	318,666
Issued to professional services providers	150,000
Exercised	(630,053)
Expired	(22,860)
Outstanding Ending Balance	4,676,361
Series F Convertible Preferred Stock [Member]
Issued to common stock offering underwriters	186,347

Equity and Equity Transaction_6

Equity and Equity Transactions - Additional Information (Details)	Aug. 11, 2020USD ($)$ / sharesshares	Jul. 29, 2020USD ($)$ / sharesshares	Jul. 27, 2020USD ($)$ / sharesshares	Jul. 21, 2020USD ($)shares	Jul. 13, 2020USD ($)$ / sharesshares	Apr. 06, 2020USD ($)$ / sharesshares	Mar. 18, 2020USD ($)shares	Mar. 09, 2020$ / sharesshares	Aug. 11, 2020USD ($)$ / shares	Sep. 30, 2020USD ($)$ / sharesshares	Jun. 30, 2020$ / sharesshares	Sep. 30, 2019USD ($)shares	Sep. 30, 2020USD ($)$ / sharesshares	Sep. 30, 2019USD ($)shares	Jul. 26, 2020$ / shares	Dec. 31, 2019USD ($)$ / sharesshares
Common Stock, Shares Authorized										50,000,000			50,000,000			50,000,000
Common stock, par value | $ / shares						$ 2.30				$ 0.0001			$ 0.0001			$ 0.0001
Preferred Stock, Shares Authorized										10,000,000			10,000,000			10,000,000
Common Stock, Shares, Issued										23,354,130			23,354,130			17,300,899
Preferred stock, Designated shares										3,209,210			3,209,210			3,179,120
Dividends Payable | $										$ 1,602,675			$ 1,602,675
Description of Equity Method Investment Ownership Percentage													The consolidated financial statements include less than 100% owned and controlled subsidiaries
Equity Method Investment, Description of Principal Activities													include equity attributable to non-controlling interests that take the form of the underlying legal structures of the less than 100% owned subsidiaries
Preferred Stock Initial Closing Cost | $							$ 1,500,000
Preferred Stock New Series Shares							13,045
Common Stock Warrants						7,750	178,597
Warrant valuations | $						$ 2,205	$ 50,836
Issuance cost | $							$ 4,550
Warrants Expiration Period						5 years
Warrants issued											630,053
Gross proceeds of the offering | $													$ 9,470,825
Legal fees | $													139,033
Share price | $ / shares			$ 1.81
Number of shares converted											372,304
Preferred Stock, Value, Issued | $
Preferred stock, stated value | $										$ 626,553			$ 626,553			$ 726,553
Conversion of preferred stock into common										239,566		90,000	239,566	90,000
Value of shares issued for payment of accrued dividend | $										$ 17,840			$ 42,840
Preferred Stock, Par or Stated Value Per Share | $ / shares										$ 0.0001			$ 0.0001			$ 0.0001
Class of Warrant or Right, Outstanding										4,676,361			4,676,361			4,674,261
Class of Warrant or Right										4,676,361			4,676,361			4,674,261
Warrants term					5 years
Warrants modification | $														$ 49,160
Preferred Stock, Shares Outstanding										848,292			848,292			856,181
Warrants to acquire shares of common stock											630,053
Issuance of registered common shares, net of offering costs | $										$ 8,437,480		$ 3,035,557	$ 8,437,480	$ 3,035,557
Payments in common stock and warrants to vendors and creditors (in shares)													141,259
Number of shares converted											372,304
Issued to common stock offering underwriters													318,666
Issued to professional services providers													150,000
Exercise price of warrants | $ / shares			$ 1.81		$ 1.80						$ 1.80				$ 2.30
Warrants issued to several professional service providers | $			$ 21,738		$ 150,000
Warrants expiration period					5 years
Underwriting agreement
Common stock, par value | $ / shares	$ 1.81		$ 1.81						$ 1.81
Warrants issued		318,666
Shares Issued, Price Per Share | $ / shares	$ 1.81		$ 1.81						1.81
Issuance of registered common shares, net of offering costs (in shares)	682,500		4,550,000
Price per share | $ / shares	$ 1.81		$ 1.81						$ 1.81
Period to purchase additional shares			45 days
Percentage of underwriting discounts and commission		9.00%
Underwriting commissions | $		$ 741,195
Reimbursement of counsel fees | $		$ 65,000
Warrants to acquire shares of common stock		318,666
Warrants exercisable period		180 days
Percentage of offering price		110.00%
Period for underwriters piggy-back registration rights		5 years
Issuance of registered common shares, net of offering costs | $	$ 1,235,325
Net proceeds after underwriter's commission and before other costs amount | $	$ 1,124,146								$ 8,437,480
Exercise price of warrants | $ / shares		$ 1.991
Underwriting shares
Issuance of registered common shares, net of offering costs (in shares)			682,500
Volatility
Warrants, measurement input					55.6
Risk free rate
Warrants, measurement input					0.3
Measurement Input, Expected Dividend Rate [Member]
Warrants, measurement input					0
Measurement Input, Expected Term [Member]
Warrants, measurement input					5
Common Stock [Member]
Value of shares issued for payment of accrued dividend | $										$ 1			$ 2
Issuance of registered common shares, net of offering costs (in shares)										5,232,500		1,877,666	5,232,500	1,877,666
Issuance of registered common shares, net of offering costs | $										$ 523		$ 188	$ 523	$ 188
Payments in common stock and warrants to vendors and creditors (in shares)										141,259			141,259
Series C Convertible Preferred Stock [Member]
Preferred stock, Designated shares										1,000,000			1,000,000			1,000,000
Par Value Per Share (in dollars per share) | $ / shares													$ 0.0001
Stated Value Per Share (in dollars per share) | $ / shares													$ 10
Preferred Stock, Value, Issued | $										$ 3,050,142			$ 3,050,142			$ 3,050,142
Preferred Stock, Shares Outstanding										427,500			427,500			427,500
Series A Redeemable Convertible Preferred Stock [Member]
Number of shares converted										20,000
Conversion of preferred stock into common										55,556			55,556
Value of shares issued for payment of accrued dividend | $										$ 7,350
Number of shares converted										20,000
Shares issued for payments of accrued dividend										4,083
Series F Redeemable, Convertible Preferred Stock [Member]
Common stock, par value | $ / shares								$ 2.30
Preferred stock, Designated shares								30,090
Preferred Stock Initial Closing Cost | $						$ 65,000
Preferred Stock New Series Shares						566
Par Value Per Share (in dollars per share) | $ / shares								$ 0.0001
Stated Value Per Share (in dollars per share) | $ / shares								$ 115
Conversion price (in dollars per share)			1.81%					2.10%
Period after which the preferred stock can be redeemed								24 months
Trading share price								3.00%
Daily trading volume (in shares)								50,000
Warrants Expiration Period								5 years
Preferred Stock, Dividend Rate, Percentage								9.00%
Series A Redeemable Convertible Preferred Stock
Preferred stock, Designated shares										333,401			333,401			333,401
Preferred Stock, Shares Outstanding										125,312			125,312			145,312
Series D Convertible Preferred Stock
Preferred stock, Designated shares										20,000			20,000			20,000
Par Value Per Share (in dollars per share) | $ / shares													$ 0.0001
Stated Value Per Share (in dollars per share) | $ / shares													$ 100
Number of shares converted					1,500
Preferred Stock, Value, Issued | $										$ 1,365,696			$ 1,365,696			$ 1,505,262
Conversion of preferred stock into common					83,334
Value of shares issued for payment of accrued dividend | $				$ 17,840	$ 14,388
Preferred Stock, Shares Outstanding										17,350			17,350			18,850
Number of shares converted					1,500
Shares issued for payments of accrued dividend				9,912	7,994
Series F Convertible Preferred Stock [Member]
Preferred stock, Designated shares										30,090			30,090
Par Value Per Share (in dollars per share) | $ / shares													$ 0.0001
Stated Value Per Share (in dollars per share) | $ / shares													$ 115
Preferred Stock, Value, Issued | $										$ 1,507,408			$ 1,507,408			$ 0
Preferred Stock, Shares Outstanding										13,611			13,611			0
Issued to common stock offering underwriters													186,347

Equity Incentive Plans - Compen

Equity Incentive Plans - Compensation Expenses Related to Stock Options (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Stock options	$ 34,605	$ 31,323	$ 124,383	$ 104,075
Restricted stock	438,042	178,262	940,886	637,113
Total			1,537,915	741,188
Rental Service And Maintenance [Member]
Total	2,097	3,353	8,416	12,426
Selling, General and Administrative Expenses [Member]
Total	470,550	206,232	1,056,853	728,762
Stock And Restricted Stock [Member]
Total	$ 472,647	$ 209,585	$ 1,065,269	$ 741,188

Equity Incentive Plans - Stock

Equity Incentive Plans - Stock option activity (Details) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Equity Incentive Plans
Number of options, Beginning Balance	363,826
Number of Options, Granted or vested	155,450
Number of Options, Forfeited or Canceled	(58,417)
Number of Options, Ending Balance	460,859	363,826
Number of Options, Exercisable, Ending Balance	307,021
Weighted Average Exercise Price, Beginning Balance	$ 3.71
Weighted Average Exercise Price, Granted or vested	2
Weighted Average Exercise Price, Forfeited or Canceled	3.57
Weighted Average Exercise Price, Ending Balance	3.16	$ 3.71
Weighted Average Exercise Price, Exercisable	$ 3.49
Weighted Average Remaining Contractual Life (in Years), Outstanding	7 years 6 months 7 days	7 years 4 months 2 days
Weighted Average Remaining Contractual Life (in Years), Exercisable	6 years 10 months 10 days

Equity Incentive Plans - Schedu

Equity Incentive Plans - Schedule of Restricted Stock (Details)	9 Months Ended
	Sep. 30, 2020shares
Equity Incentive Plans
Unvested balance at beginning	291,730
Grants	405,205
Vested	(403,233)
Unvested balance at end	293,702

Equity Incentive Plans - Additi

Equity Incentive Plans - Additional Information (Details) - USD ($)	Sep. 19, 2020	Jul. 23, 2020	Jan. 30, 2020	Sep. 30, 2020	Dec. 31, 2017	Dec. 31, 2015
Restricted Stock Units				405,205
Number of shares calculated				136,145
Interim Executive plan expenses				$ 174,266
Restricted Stock Units (RSUs) [Member]
Restricted Stock Units	136,145			804,221
Market value on the date of the grants	$ 174,266
Equity Incentive Plan 2015 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized		1,250,000				750,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized		500,000
Executive Incentive Plan 2017 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized		1,500,000			1,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized		500,000
Nonqualified Options			155,450
Restricted Stock Units			269,060
Fair value options, Granted			$ 162,959
Risk-free Interest Rate			1.44%
Expected dividend yield			0.00%
Expected volatility			49.24%
Weighted average vesting period			9 months
Restricted Stock Value			$ 538,120
Executive Incentive Plan 2017 [Member] | Minimum [Member]
Expected term in years			1 year
Executive Incentive Plan 2017 [Member] | Maximum [Member]
Expected term in years			2 years 11 months 1 day

Revenue (Details)

Revenue (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Disaggregation of Revenue [Line Items]
Total Revenue	$ 742,877	$ 1,426,775	$ 3,376,150	$ 3,212,689
Rental of digesters
Disaggregation of Revenue [Line Items]
Total Revenue	356,001	369,438	1,054,534	1,061,289
Services
Disaggregation of Revenue [Line Items]
Total Revenue	250,177	960,146	1,428,017	1,929,174
Product sales
Disaggregation of Revenue [Line Items]
Total Revenue	$ 136,699	$ 97,191	$ 893,599	$ 222,226

Risk Concentrations (Details)

Risk Concentrations (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Concentration Risk [Line Items]
Revenue	$ 742,877	$ 1,426,775	$ 3,376,150	$ 3,212,689
Non-current tangible assets	37,764,487		37,764,487		$ 39,159,658
United States [Member]
Concentration Risk [Line Items]
Revenue	631,450	1,333,878	3,079,083	2,877,157
Non-current tangible assets	37,469,194		37,469,194		38,803,833
International [Member]
Concentration Risk [Line Items]
Revenue	111,427	$ 92,897	297,067	$ 335,532
Non-current tangible assets	$ 295,293		$ 295,293		$ 355,825

Risk Concentrations - Additiona

Risk Concentrations - Additional Information (Details)	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2020itemcustomer	Sep. 30, 2019itemcustomer	Jun. 30, 2019	Sep. 30, 2020itemcustomer	Sep. 30, 2019itemcustomer	Dec. 31, 2019customer
Gold Medal Group [Member] | Gold Medal Holdings [Member]
Concentration Risk [Line Items]
Ownership Percentage by Parent	40.00%			40.00%
Sales Revenue, Net [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	45.10%			11.40%
Sales Revenue, Net [Member] | Customer One [Member]
Concentration Risk [Line Items]
Number of customers		1			1
Concentration Risk, Percentage		10.00%			10.00%
Sales Revenue, Net [Member] | Customers Two [Member]
Concentration Risk [Line Items]
Number of customers	2
Concentration Risk, Percentage	10.00%			10.00%
Sales Revenue, Net [Member] | Customer Three [Member]
Concentration Risk [Line Items]
Number of customers				2
Sales Revenue, Net [Member] | Gold Medal Group [Member] | Customer One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		58.90%			49.20%
Sales Revenue, Net [Member] | Gold Medal Group [Member] | Customers Two [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	18.90%			32.50%
Accounts Receivable [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage				11.50%
Accounts Receivable [Member] | Customer One [Member]
Concentration Risk [Line Items]
Number of customers						1
Concentration Risk, Percentage						10.00%
Accounts Receivable [Member] | Customer Three [Member]
Concentration Risk [Line Items]
Number of customers				3
Concentration Risk, Percentage				10.00%
Accounts Receivable [Member] | Gold Medal Group [Member] | Customer One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage						58.90%
Accounts Receivable [Member] | Gold Medal Group [Member] | Customer Three [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage				63.40%
Accounts Payable [Member] | Vendor One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage				10.00%		10.00%
Accounts Payable [Member] | Gold Medal Group [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage				31.80%		54.40%
Cost Of Revenue [Member] | Shareholder One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		1.20%
Cost Of Revenue [Member] | Vendor One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	10.00%			10.00%
Number of vendors | item	1			1
Cost Of Revenue [Member] | Vendor Two [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		10.00%			10.00%
Number of vendors | item		2			2
Cost Of Revenue [Member] | Vendor Two [Member] | Gold Medal Holdings [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		18.90%			16.30%
Cost Of Revenue [Member] | Gold Medal Group [Member] | Shareholder One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage					1.20%
Cost Of Revenue [Member] | Gold Medal Group [Member] | Vendor One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	14.20%			26.10%
Cost Of Revenue [Member] | Gold Medal Group [Member] | Vendor Two [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage			21.50%		11.90%

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($)	Mar. 12, 2020	Sep. 30, 2020	Sep. 30, 2020
Impairment charge		$ 917,420	$ 917,420
Settled litigation - Litigation for alleged breach of contract and unjust enrichment on the company's resource recovery facility
Total amount payable	$ 775,000
Amount payable on the execution of the settlement agreement	$ 475,000
Execution period for the settlement agreement	60 days
Amount payable as monthly installments	$ 25,000
Number of installment months	12 months
Facility Services Contracted Related Matters [Member] | Entsorga West Virginia LLC [Member] | Claims by Related Party [Member]
Loss Contingency, Damages Sought, Value		917,420
Impairment charge		$ 917,420	$ 917,420

Leases (Details)

Leases (Details)	Sep. 30, 2020USD ($)
Leases
2020 (remaining)	$ 51,783
2021	212,026
2022	217,571
2023	219,140
2024 and thereafter	3,133,649
Total lease payments	3,834,169
Less imputed interest	(2,419,658)
Present value of lease liabilities	$ 1,414,511

Leases - Additional Information

Leases - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Lessee, Lease, Description [Line Items]
Operating Lease Renewal Term	5 years		5 years
operating lease cost	$ 178,545	$ 210,709	$ 952,931	$ 354,733
Current portion of lease liabilities	207,515		207,515
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability			412,647
Operating cash flow for operating leases	$ 51,783	51,406	$ 140,837	143,597
Land Lease [Member]
Lessee, Lease, Description [Line Items]
Operating lease initial term	30 years		30 years
Leases utilization percentage			11.00%
Other Lease [Member]
Lessee, Lease, Description [Line Items]
Leases utilization percentage			10.25%
Research And Development Lease [Member]
Lessee, Lease, Description [Line Items]
operating lease cost	$ 57,129	$ 55,356	$ 167,841	$ 166,067
Weighted average remaining term (in years)	19 years 8 months 12 days		19 years 8 months 12 days

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Assets:
Accounts receivable	$ 3,311,519		$ 3,311,519		$ 2,155,921
Liabilities:
Accounts payable	6,363,168		6,363,168		4,688,339
Accrued interest payable	627,112		627,112		1,148,570
Long term accrued interest	1,729,605		1,729,605		1,510,193
Advances from related parties	935,000		935,000		210,000
Other:
HEBioT revenue	115,173	$ 590,262	970,943	$ 831,274
Operating expenses - HEBioT	178,545	210,709	952,931	354,733
Operating expenses - Selling, general and administrative		24,537	41,514	73,611
Interest expense	98,571	76,611	295,592	194,266
Related Party [Member]
Assets:
Accounts receivable	2,227,224		2,227,224		1,370,867
Intangible assets, net, included in other assets	25,249		25,249		40,399
Liabilities:
Accounts payable	3,851,722		3,851,722		2,531,034
Accrued interest payable	165,396		165,396		46,796
Long term accrued interest	1,729,605		1,729,605		1,510,193
Advances from related parties	935,000		935,000		210,000
Junior promissory note	965,881		965,881		949,434
Other:
Line of credit guarantee	1,497,950		1,497,950		$ 1,479,848
Technology Service [Member]
Other:
Operating expenses - Selling, general and administrative	110,650	110,650	332,016	258,050
Debt guarantee fees [Member]
Other:
Revenue from Contract with Customer, Including Assessed Tax	16,875	16,875	50,625	50,625
Management Advisory Fees [Member]
Other:
Revenue from Contract with Customer, Including Assessed Tax	$ 25,000	$ 250,000	$ 125,000	$ 750,000

Related Party Transaction - Add

Related Party Transaction - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Mar. 31, 2020	Sep. 30, 2020
Related Party Transaction [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	5.00%		5.00%
Impairment charge	$ 917,420		$ 917,420
Chief Executive Officer
Related Party Transaction [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	13.00%		13.00%
Other Officer [Member]
Related Party Transaction [Line Items]
Proceeds from Related Party Debt		$ 200,000
Facility Services Contracted Related Matters [Member] | Claims by Related Party [Member] | Entsorga West Virginia LLC [Member]
Related Party Transaction [Line Items]
Loss Contingency, Damages Sought, Value	$ 917,420
Impairment charge	$ 917,420		$ 917,420
Refuel America LLC [Member]
Related Party Transaction [Line Items]
Equity Method Investment, Ownership Percentage	40.00%		40.00%

Supplemental Consolidated Sta_3

Supplemental Consolidated Statement of Cash Flows Information (Details) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Dec. 31, 2018
Changes in operating assets and liabilities:
Accounts receivable	$ (1,302,729)	$ (1,335,024)
Inventory	(210,886)	(181,979)
Prepaid expenses and other assets	(94,156)	(3,300)
Accounts payable	1,149,030	3,111,285
Accrued interest payable	(322,753)	(260,046)
Accrued expenses	(843,188)	(2,504,724)
Deferred revenue	6,921	(1,131)
Customer deposits	708,254	37,109
Net change in operating assets and liabilities	(909,507)	(1,137,810)
Supplementary cash flow information:
Interest	1,596,332	2,625,018
Income taxes	0	0
Supplementary Disclosure of Non-Cash Investing and Financing Activities:
Transfer of inventory to leased equipment	84,501	259,449
Accrual of Series A preferred stock dividends	$ 52,654	$ 140,631
Conversion of preferred stock into common	239,566	90,000
Payment of preferred stock dividends in common stock	$ 21,732	$ 50,000
Acquisition of right of use leased asset and creation of lease liability	412,647	0
Reconciliation of Cash and Restricted Cash:
Cash	4,950,112	3,434,089	$ 1,847,526
Restricted cash (current)	1,287,138	1,128,716	1,133,581
Restricted cash (non-current)	2,646,448	2,544,948
Total cash and restricted cash at the end of the period	$ 8,883,698	$ 7,107,753	$ 5,536,952	$ 9,126,380

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Jul. 27, 2020	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Oct. 19, 2020	Jun. 30, 2020	Apr. 06, 2020	Dec. 31, 2019
Subsequent Event [Line Items]
Warrants to purchase aggregate shares of the common stock						630,053
Common stock, par value		$ 0.0001	$ 0.0001				$ 2.30	$ 0.0001
Net proceeds of the offering	$ 8,235,500	$ 8,437,480	$ 8,437,480	$ 3,035,557
Underwriting shares
Subsequent Event [Line Items]
Common stock, par value	$ 0.0001
Subsequent events | Membership Interest Purchase Agreement
Subsequent Event [Line Items]
Percentage of newly-issued membership interests					49.00%
Consideration for issuance of membership interest					$ 650,000
Warrants to purchase aggregate shares of the common stock					100,000
Common stock, par value					$ 0.0001

Condensed Consolidating Finan_3

Condensed Consolidating Financial Information (Details) - USD ($)	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Dec. 31, 2018
Current Assets
Cash	$ 4,950,112		$ 1,847,526
Restricted Cash	1,287,138		1,133,581
Other current assets	4,179,719		2,750,062
Current Assets	10,416,969		5,731,169
Restricted cash	2,646,448		2,555,845
HEBioT facility under construction, net	37,755,987		39,146,331
Operating lease right of use assets	1,285,292		945,047
MBT facility development and license costs	8,018,853		8,049,929
Investment in subsidiaries and intercompany accounts	0		0
Goodwill	58,000		58,000
Other assets	33,749		53,726
Total Assets	60,215,298		56,540,047
Total assets	60,215,298
Liabilities, Current [Abstract]
Line of credit	1,497,950		1,479,848
Current portion of Debts and Bonds	7,530,301		1,390,000
Other current liabilities	10,849,233		8,213,007
Total Current Liabilities	19,877,484		11,082,855
Notes payable and other debts	1,234,656		5,118,125
Accrued interest	1,729,605		1,510,193
Non-current lease liabilities	1,231,144		915,170
WV EDA bonds	28,448,484		29,817,426
Total Liabilities	52,521,373		48,443,769
Redeemable preferred stock	626,553		726,553
Stockholders' equity :
Attributable to parent	4,912,578	$ (1,038,936)	2,024,143	$ 3,922,118	$ 1,880,500	$ 3,405,551
Attributable to non-controlling interests	2,154,794	$ 3,802,576	5,345,582	$ 6,143,626	$ 6,871,963	$ 6,602,695
Stockholders' equity	7,067,372		7,369,725
Total liabilities and stockholders' equity	60,215,298		56,540,047
Consolidation, Eliminations [Member]
Current Assets
Cash	0		0
Restricted Cash	0		0
Other current assets	0		(64,669)
Current Assets	0		(64,669)
Restricted cash	0		0
HEBioT facility under construction, net	0		0
Operating lease right of use assets	0		0
MBT facility development and license costs	0		0
Investment in subsidiaries and intercompany accounts	(16,444,214)		(10,864,783)
Goodwill	0		0
Other assets	0		0
Total Assets			(10,929,452)
Total assets	(16,442,214)
Liabilities, Current [Abstract]
Line of credit	0		0
Current portion of Debts and Bonds	0		0
Other current liabilities	(5,948,711)		(650,894)
Total Current Liabilities	(5,948,711)		(650,894)
Notes payable and other debts	0		0
Accrued interest	0		0
Non-current lease liabilities	0		0
WV EDA bonds	0		0
Total Liabilities	(5,948,711)		(650,894)
Redeemable preferred stock	0		0
Stockholders' equity :
Attributable to parent	(10,495,503)		0
Attributable to non-controlling interests	0		(10,278,558)
Stockholders' equity	(10,495,503)		(10,278,558)
Total liabilities and stockholders' equity	(16,444,214)		(10,929,452)
Entsorga West Virginia LLC [Member]
Current Assets
Cash	1,770		0
Restricted Cash	1,287,138		1,133,581
Other current assets	2,094,211		1,116,821
Current Assets	3,383,119		2,250,402
Restricted cash	2,646,448		2,555,845
HEBioT facility under construction, net	36,317,732		37,392,601
Operating lease right of use assets	888,730		897,026
MBT facility development and license costs	1,701,000		1,795,500
Investment in subsidiaries and intercompany accounts	0		0
Goodwill	58,000		58,000
Other assets	0		0
Total Assets			44,949,374
Total assets	44,995,029
Liabilities, Current [Abstract]
Line of credit	0		0
Current portion of Debts and Bonds	2,860,000		1,390,000
Other current liabilities	13,081,770		6,475,985
Total Current Liabilities	15,941,770		7,865,985
Notes payable and other debts	0		0
Accrued interest	0		0
Non-current lease liabilities	944,830		915,170
WV EDA bonds	28,448,484		29,817,426
Total Liabilities	45,335,084		38,598,581
Redeemable preferred stock	0		0
Stockholders' equity :
Attributable to parent	(340,055)		0
Attributable to non-controlling interests	0		6,350,793
Stockholders' equity	(340,055)		6,350,793
Total liabilities and stockholders' equity	44,995,029		44,949,374
Parent Company [Member]
Current Assets
Cash	4,948,342		1,847,526
Restricted Cash	0		0
Other current assets	2,085,508		1,697,910
Current Assets	7,033,850		3,545,436
Restricted cash	0		0
HEBioT facility under construction, net	1,438,255		1,753,730
Operating lease right of use assets	396,562		48,021
MBT facility development and license costs	6,317,853		6,254,429
Investment in subsidiaries and intercompany accounts	16,444,214		10,864,783
Goodwill	0		0
Other assets	33,749		53,726
Total Assets			22,520,125
Total assets	31,664,483
Liabilities, Current [Abstract]
Line of credit	1,497,950		1,479,848
Current portion of Debts and Bonds	4,670,301		0
Other current liabilities	3,716,174		2,387,916
Total Current Liabilities	9,884,425		3,867,764
Notes payable and other debts	1,234,656		5,118,125
Accrued interest	1,729,605		1,510,193
Non-current lease liabilities	286,314		0
WV EDA bonds	0		0
Total Liabilities	13,135,000		10,496,082
Redeemable preferred stock	626,553		726,553
Stockholders' equity :
Attributable to parent	15,748,136		2,024,143
Attributable to non-controlling interests	2,154,794		9,273,347
Stockholders' equity	17,902,930		11,297,490
Total liabilities and stockholders' equity	$ 31,664,483		$ 22,520,125

Condensed Consolidating Finan_4

Condensed Consolidating Financial Information - Statement of Operations (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenues	$ 742,877	$ 1,426,775	$ 3,376,150	$ 3,212,689
Cost of revenue		24,537	41,514	73,611
Operating Expenses [Abstract]
Selling, general and administrative	1,924,293	1,449,545	5,740,158	5,450,282
Impairment expense	917,420		917,420
Depreciation and amortization	562,143	611,368	1,747,109	1,350,780
Total operating expenses	4,660,333	3,042,020	12,052,802	8,674,904
Loss from operations	(3,917,456)	(1,615,245)	(8,676,652)	(5,462,215)
Other (income) expenses, net	1,023,057	419,565	3,043,045	1,721,434
Net loss	(4,940,513)	(2,034,810)	(11,719,697)	(7,183,649)
Consolidation, Eliminations [Member]
Revenues	0	0	0	0
Operating Expenses [Abstract]
Selling, general and administrative	0	0	0	0
Impairment expense	0		0
Depreciation and amortization	0	0	0	0
Total operating expenses	0	0	0	0
Loss from operations	0	0	0	0
Other (income) expenses, net	0	0	0	86,362
Net loss	0	0	0	(86,362)
Entsorga West Virginia LLC [Member]
Revenues	625	609,905	1,383,656	886,947
Operating Expenses [Abstract]
Selling, general and administrative	494,198	246,026	1,026,235	771,867
Impairment expense	917,420		917,420
Depreciation and amortization	437,384	490,469	1,373,004	980,937
Total operating expenses	2,794,812	1,523,175	6,095,173	3,061,980
Loss from operations	(2,794,187)	(913,270)	(4,711,517)	(2,175,033)
Other (income) expenses, net	686,308	600,402	1,979,331	1,361,221
Net loss	(3,480,495)	(1,513,672)	(6,690,848)	(3,536,254)
Parent Company [Member]
Revenues	742,252	816,870	1,992,494	2,325,742
Operating Expenses [Abstract]
Selling, general and administrative	1,430,095	1,203,519	4,713,923	4,678,415
Impairment expense	0		0
Depreciation and amortization	124,759	120,899	374,105	369,843
Total operating expenses	1,865,521	1,518,845	5,957,629	5,612,924
Loss from operations	(1,123,269)	(701,975)	(3,965,135)	(3,287,182)
Other (income) expenses, net	336,749	(180,837)	1,063,714	273,851
Net loss	(1,460,018)	(521,138)	(5,028,849)	(3,561,033)
HEBioT (related entity)
Cost of revenue	945,810	786,680	2,778,514	1,309,176
HEBioT (related entity) | Consolidation, Eliminations [Member]
Cost of revenue	0	0	0	0
HEBioT (related entity) | Entsorga West Virginia LLC [Member]
Cost of revenue	945,810	786,680	2,778,514	1,309,176
HEBioT (related entity) | Parent Company [Member]
Cost of revenue	0	0	0	0
Rental, service and maintenance
Cost of revenue	139,665	176,651	552,195	508,164
Rental, service and maintenance | Consolidation, Eliminations [Member]
Cost of revenue	0	0	0	0
Rental, service and maintenance | Entsorga West Virginia LLC [Member]
Cost of revenue	0	0	0	0
Rental, service and maintenance | Parent Company [Member]
Cost of revenue	139,665	176,651	552,195	508,164
Equipment sales
Cost of revenue	171,002	17,776	317,406	56,502
Equipment sales | Consolidation, Eliminations [Member]
Cost of revenue	0	0	0	0
Equipment sales | Entsorga West Virginia LLC [Member]
Cost of revenue	0	0	0	0
Equipment sales | Parent Company [Member]
Cost of revenue	$ 171,002	$ 17,776	$ 317,406	$ 56,502

Condensed Consolidating Finan_5

Condensed Consolidating Financial Information - Statement of Cash Flow (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net loss	$ (4,940,513)	$ (2,034,810)	$ (11,719,697)	$ (7,183,649)
Non-cash adjustments to reconcile net loss to net cash used in operations			5,118,515	2,303,947
Changes in operating assets and liabilities			(909,507)	(1,137,810)
Net cash used in operations			(7,510,689)	(6,017,512)
Cash flow from investing activities:
Purchases of construction in-progress, equipment, fixtures and vehicles			(207,173)	(4,619,883)
Capital contribution to Entsorga West Virginia, LLC				0
Other investing activities			(57,949)	(2,256,987)
Net cash used in investing activities			(265,122)	(2,362,896)
Cash flows from financing activities:
Issuances of debt and equity			11,144,230	6,418,057
Repayments of debt			(3,544)	(6,846)
Deferred financing costs incurred				(62,151)
Net cash provided by financing activities			11,140,686	6,349,060
Effect of exchange rate on cash (restricted and unrestricted)			(18,129)	12,721
Cash - beginning of period (restricted and unrestricted)			5,536,952	9,126,380
Cash - end of period (restricted and unrestricted)	8,883,698	7,107,753	8,883,698	7,107,753
Consolidation, Eliminations [Member]
Cash flows from operating activities:
Net loss	0	0	0	(86,362)
Non-cash adjustments to reconcile net loss to net cash used in operations			0	86,362
Changes in operating assets and liabilities			0	0
Net cash used in operations			0	0
Cash flow from investing activities:
Purchases of construction in-progress, equipment, fixtures and vehicles			0	0
Capital contribution to Entsorga West Virginia, LLC				4,586,362
Other investing activities			0	0
Net cash used in investing activities			0	4,586,362
Cash flows from financing activities:
Issuances of debt and equity			0	(4,586,362)
Repayments of debt			0	0
Deferred financing costs incurred				0
Net cash provided by financing activities			0	(4,586,362)
Effect of exchange rate on cash (restricted and unrestricted)			0	0
Cash - beginning of period (restricted and unrestricted)			0	0
Cash - end of period (restricted and unrestricted)	0	0	0	0
Entsorga West Virginia LLC [Member]
Cash flows from operating activities:
Net loss			(6,690,848)	(3,536,254)
Non-cash adjustments to reconcile net loss to net cash used in operations			2,424,869	1,064,563
Changes in operating assets and liabilities			4,715,544	(440,212)
Net cash used in operations			449,565	(2,911,903)
Cash flow from investing activities:
Purchases of construction in-progress, equipment, fixtures and vehicles			(203,635)	(4,619,981)
Capital contribution to Entsorga West Virginia, LLC				0
Other investing activities			0	0
Net cash used in investing activities			(203,635)	(4,619,981)
Cash flows from financing activities:
Issuances of debt and equity			0	4,586,362
Repayments of debt			0	0
Deferred financing costs incurred				(62,151)
Net cash provided by financing activities			0	4,524,211
Effect of exchange rate on cash (restricted and unrestricted)			0	0
Cash - beginning of period (restricted and unrestricted)			3,689,426	6,715,672
Cash - end of period (restricted and unrestricted)	3,935,356	3,707,999	3,935,356	3,707,999
Parent Company [Member]
Cash flows from operating activities:
Net loss	(1,460,018)	(521,138)	(5,028,849)	(3,561,033)
Non-cash adjustments to reconcile net loss to net cash used in operations			2,693,646	1,153,022
Changes in operating assets and liabilities			(5,625,051)	(697,598)
Net cash used in operations			(7,960,254)	(3,105,609)
Cash flow from investing activities:
Purchases of construction in-progress, equipment, fixtures and vehicles			(3,538)	98
Capital contribution to Entsorga West Virginia, LLC				(4,586,362)
Other investing activities			(57,949)	(2,256,987)
Net cash used in investing activities			(61,487)	(2,329,277)
Cash flows from financing activities:
Issuances of debt and equity			11,144,230	6,418,057
Repayments of debt			(3,544)	(6,846)
Deferred financing costs incurred				0
Net cash provided by financing activities			11,140,686	6,411,211
Effect of exchange rate on cash (restricted and unrestricted)			(18,129)	12,721
Cash - beginning of period (restricted and unrestricted)			1,847,526	2,410,708
Cash - end of period (restricted and unrestricted)	$ 4,948,342	$ 3,399,754	$ 4,948,342	$ 3,399,754